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Summary  
 
LINC (Linker of nucleoskeleton and cytoskeleton) complexes connect the nucleoskeleton to 
the cytoskeleton by interactions among LINC complex proteins and their interactions to 
proteins in the nucleus and the cytosol. Nesprins (nuclear envelope spectrin repeat proteins) 
are core components of the LINC complex, together with their interaction partners along the 
nuclear envelope, such as lamins that form meshwork along inner nuclear membrane, they 
play critical roles in regulating many cellular functions including the maintenance of the 
structural integrity of nucleus and cytoskeleton or proper signal transduction across the NE. 
Mutations in LINC complex or associated proteins, especially in lamin A/C, result in a variety 
of human diseases such as muscular dystrophies, neuropathies, lipodystrophy and progeria, 
that are collectively known as laminopathies.  
 
Here we narrowed down the binding site between nesprin-2 and lamin A to aa 403-425 in 
lamin A and aa 6146-6347 in nesprin-2. Additionally, laminopathy causing mutations in or 
near the binding sites of both proteins were analyzed in this study. Currently only mutations 
in LMNA encoding lamin A/C have been described along the interaction sites. The lamin A 
mutations R401C (1201 C>T), G411D (1232G>A), G413C (1237G>T), V415I (1243G>A), R419C 
(1255T>C), L421P (1261T>C), R427G (1279C>G) and Q432X (1294C>T) were analyzed in this 
study. All lamin A mutations analyzed here lie in a loop between the central alpha helical rod 
and the C-terminal globular tail and are thus accessible for interaction. They modulate the 
interaction with nesprin-2 in a range from increasing to decreasing. The wide range of 
variations reflects the wide range of diseases caused by the mutations analyzed here, 
indicating that altered biochemical properties among distinct LINC complex components 
contribute to the formation of distinct laminopathies with different phenotypes. The most 
notable mutation was the lamin A mutation Q432X that formed aggregates along the NE and 
altered LINC complex protein assemblies by the sequestration of nesprin-2, lamin B1, emerin 
or lamin A/C. Additionally Q432X aggregates altered chromatin structure and transcription 
factor arrangements. 
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Zusammenfassung  
 
LINC (Linker of nucleoskeleton and cytoskeleton)Komplexe verbinden das Zellkerngerüst mit 
dem Zytoskelett durch Interaktionen von LINC Komplex Komponenten und weiteren 
Interaktionen mit Proteinen des Zellkerns und des Zytoplasmas. Nesprine (nuclear envelope 
spectrin repeat proteins) sind  Kernkomponenten des LINC Komplexes, die zusammen mit 
ihren Interaktionspartnern an der Kernhülle, wie den Laminen, die entlang der inneren 
Kernmembran ein Geflecht bilden, essentielle Funktionen in der Regulation verschiedener 
zellulärer Prozesse wie die Aufrechterhaltung der strukturellen Integrität des Zellkerns, des 
Zytoskeletts oder einer geregelten Signaltransduktion entlang die Zellkernhülle, 
übernehmen. Mutationen in Komponenten des LINC Komplexes oder in assoziierten 
Proteinen, insbesondere in Lamin A/C, führen zu einer Vielzahl von menschlichen 
Krankheiten wie Muskeldystrophien, Neuropathien, Lipodystrophien oder Progerie, die als 
Laminopathien zusammengefasst werden. 
 
Wir haben hier die Bindestellen zwischen nesprin-2 und lamin A auf die 
Aminosäuresequenzen 403-425 in lamin A und 6146-6347 in Nesprin-2 eingeengt. Zusätzlich 
wurden in der vorgelegten Arbeit Laminopathien verursachende Mutationen in bzw. nahe 
der Bindestellen beider Proteine untersucht. Bisher wurden in den Interaktionsbereichen 
beider Proteine lediglich Mutationen in LMNA, welches für Lamin A/C kodiert, beschrieben. 
Die Lamin A Mutationen R401C (1201 C>T), G411D (1232G>A), G413C (1237G>T), V415I 
(1243G>A), R419C (1255T>C), L421P (1261T>C), R427G (1279C>G) und Q432X (1294C>T) 
wurden in dieser Studie untersucht. Jede dieser Mutationen befindet sich in in einer 
Schleifenstruktur, die zwischen der alpha helikalen, zentralen Domäne und der C-terminalen 
globulären Domäne von Lamin A/C liegt, was sie zugängig für Interaktionen macht. Die 
Ergebnisse zeigen, dass alle hier untersuchten Lamin A Mutationen die Interaktion zu 
Nesprin-2 modulieren, in einem Spektrum das von einer verstärkten bis hin zu einer 
abgeschwächten Interaktion reicht. Dieses große Spektrum an Variationen in den 
Bindungseigenschaften beider Proteine, spiegelt das große Spektrum an Krankheiten wieder, 
die durch die einzelnen Mutationen verursacht werden. Dies gibt einen Hinweis darauf, dass 
veränderte biochemische Eigenschaften zwischen LINC Komplex Komponenten zur 
Ausbildung spezifischer Phänotypen beitragen. Die bemerkenswerteste Mutation war die 
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Lamin A Mutation Q432X, welche zur Bildung von Aggregaten entlang der Kernhülle führt, in 
denen die LINC Komplexe Komponenten Nesprin-2, Emerin, lamin B1 und lamin A/C 
akkumulieren.  Zusätzlich konnten entlang der Q432X Aggregate Veränderungen in der  
Chromatin-Struktur und in der Verteilung von Transkriptionsfaktoren beobachtet werden. 
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1 Introduction 
 
1.1 Nuclear envelope 
 
As the largest organelle found in eukaryotic cells, the nucleus contains most of the genetic 
material that is organized as chromatin consisting of DNA and associated proteins.  
 
A main structural characteristic of the nucleus is the nuclear envelope (NE), which is a 
double lipid bilayer that encloses the genetic material in eukaryotic cells (Figure 1.1). It 
serves as a physical barrier, separating nucleoplasmic components from the cytosol. The 
double lipid bilayers that together from the NE are referred to as inner nuclear membrane 
(INM) or outer nuclear membrane (ONM) that are joined together at the nuclear pore 
complexes (NPC). NPCs are large macromolecular proteins assemblies responsible for the 
selective exchange between the nucleoplasm and the cytoplasm that prevents the exchange 
of materials not destined to cross the NE (Schirmer EC and Gerace L, 2002; Hertzer MW, 
2010).  
 
 
 
Figure 1.1 The nuclear envelope encloses the genetic material in eukaryotes.  
The nuclear envelope is composed of an inner and an outer nuclear membrane (INM, ONM). A network of 
proteins termed the nuclear lamina underlies the inner membrane. Nuclear pore complexes bridge this system 
and regulate nucleo-cytoplasmic exchange of macromolecules. Additionally, the ONM continuous into the 
endoplasmic reticulum (ER). The genetic material is organized as chromatin (Schirmer EC and Gerace L, 2002). 
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Electron microscopy technique revealed that ONM and INM are continuous and the ONM 
additionally extends into the endoplasmic reticulum (ER). A variety of techniques were 
applied during the last decades to reveal the complex and unique structures of the NE 
membrane system and their associated proteins. Despite the membrane continuity between 
ONM, INM and ER, recent evidence demonstrates the presence of particular proteins 
assemblies (Watson ML, 1955; Hetzer MW, et al., 2005; Hetzer MW, 2010). 
 
1.2 NE proteins 
 
Along the NE one can observe the formation of distinct protein networks. In the following 
parts structures and functions of NE protein components will be described. 
 
1.2.1 Nuclear pore complexes 
 
NPCs are formed at sites where the inner and outer membranes of the nuclear envelope are 
joined, and are constructed of multiple copies of approximate 30 different proteins named 
nucleoporins (Nups). NPCs consist of three functional regions: First, the NPC scaffold and 
central transport channel, which is embedded in the plane of the nuclear envelope; second, 
peripheral structures, nuclear ring/nuclear basket; third, cytoplasmic ring/cytoplasmic 
filaments, which extend to the cytoplasmic or nucleoplasmic end of the NPCs. 
 
The primary function of NPCs is that they regulate molecular trafficking between cytoplasm 
and nucleus that is crucial for maintaining the unique composition of both compartments. 
NPCs allow the free transport of ions and small molecules without specific transport partner. 
Large molecules like m-RNA or proteins with a molecular weight of more than 40~60 kDa are 
transported between nucleoplasm and cytoplasm by binding to nuclear transport receptors 
(Strambio-De-Castillia C, et al., 2010; Chow KH, et al., 2012; Raices M and D’Angelo MA, 
2012). 
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1.2.2 The LINC Complex 
 
Along nuclear membranes, proteins assemble to form large protein complexes. At the INM, 
lamins form a meshwork that stabilizes nuclear morphology. NPCs are integrated into the NE 
and allow the passive and selective transport across the nuclear membranes. SUN proteins, 
lamins and nesprins, which will be described later in detail, are part of large protein 
complexes that traverse the NE to connect the nuclear interior to the cytoplasm, known as 
the LINC complex (linker of nucleoskeleton and cytoskeleton). At the heart of the LINC 
complex are the SUN (Sad1 and UNC-84) proteins and the nesprins (nuclear envelope 
spectrin repeat proteins). The KASH (Klarsicht, ANC1 and SYNE1 homology) domain of the 
nesprins interacts with the SUN domain of the SUN proteins in the perinuclear space (PNS) 
between the INM and the ONM (Figure 1.2). 
 
 
 
Figure 1.2 Typical structure of the LINC complex. The LINC complex is composed of two major parts, ONM 
KASH domain proteins and INM SUN domain proteins. KASH domain proteins are anchored in the ONM by the 
interaction with the SUN domain of the SUN proteins in the perinuclear space (PNS) between ONM and INM. 
Together they form a physical connection between nucleoplasm and cytoplasm. On the nucleoplasmic side, 
LINC complex components interact with the lamina and INM-associated proteins such as emerin. At the 
cytoplasmatic side, nesprins directly or indirectly connect the NE to cytoskeletal components, F-actin, 
microtubules and intermediate filaments (Taranum S, et al., 2012). 
 
At the nucleoplasmic side LINC complex components interact with lamina proteins or INM-
associated protein such as emerin or chromosomes. On the cytoplasmic side they directly or 
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indirectly bind to cytoskeletal components like F-actin, microtubules or the intermediate 
filament network (Starr DA and Fischer JA, 2005; Zhang Q, et al., 2005; Crisp M, et al., 2006; 
Tzur YB, et al., 2006; Méjat A and Misteli T, 2010; Starr DA and Fridolfsson HN, 2010; ). 
 
1.2.3 Nesprins 
 
Nesprins also known as SYNE (synaptic nuclear envelope protein), ENAPTIN and NUANCE 
(nucleus and actin connecting element) belong to a group of proteins that are primarily 
found along both, the INM and the ONM. Nesprins are spectrin repeat (SR)-containing type II 
transmembrane proteins with evolutionarily conserved orthologous in lower eukaryotes 
such as in Dictyostelium discoideum (interaptin), C. elegans (ANC-1) and Drosophila (MSP-
300) (Rivero F, et al., 1998; Apel ED, et al., 2000; Zhang Q, et al., 2001; Starr DA and Han M, 
2002; Zhen YY, et al., 2002; Padmakumar VC, et al., 2004; Yu J, et al., 2006). 
 
Four different nesprins have been described in mammals until now (nesprin-1, -2, -3 and -4). 
Each is encoded by a single gene. A multitude of isoforms has been described so far differing 
in size and domain composition which result from differential splicing and initiation of 
transcription. The largest nesprin isoforms are nesprin-1/2-giant with molecular weights of 
1014/796 kilodalton (kDa) respectively (Figure 1.3). 
 
Nesprin-1/2 giant contain N-terminal actin-binding domains (ABD) that interact with actin 
filaments. Nesprin-3 binds to plectin, which in turn binds to intermediate filaments. Nesprin-
2/4 bind to kinesin-1 and in this way they connect the nucleus to the microtubule network. 
 
At the C-terminus of almost all nesprin isoforms, there is a highly conserved KASH domain 
that contains a transmembrane region. Nesprins are anchored along the ONM or INM 
through their KASH domain that interacts with the SUN domain of the SUN proteins in the 
lumen between the INM and ONM (Zhang Q, et al., 2001; Wilhelmsen K, et al., 2005; Roux 
KJ, et al., 2009; Gob E, et al., 2010; Noegel AA and Neumann S, 2011; Taranum S, et al., 
2012) 
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Figure 1.3 Summary of mammalian nesprins and their isoforms.  
Four different nesprins have been described in mammals (nesprin-1, -2, -3 and -4). Each is encoded by a single 
gene that gives rise to several isoforms. Main structural components of the nesprins are paired calponin 
homology (CH) domains, spectrin repeats (SRs) and a KASH (Klarsicht, ANC1 and SYNE1 homology) – 
transmembrane domain (Taken and combined from Rajgor D, et al., 2012 and Mellad JA, et al., 2011). 
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Nesprins play an important role in maintaining nuclear architecture. A loss of nesprin-2 for 
example results in misshapen nuclei or nuclear blebbing. Furthermore nesprins have been 
shown to play roles in cellular processes like muscle development, cell proliferation, nuclear 
positioning and anchorage. Wound healing studies in nesprin-2 giant deficient mice showed 
that a loss of nesprin-2 giant affects wound healing particularly at later stages during 
fibroblast differentiation and keratinocyte proliferation leading to delayed wound closure. A 
loss of nesprin-1 and nesprin-2 furthermore shows those both mediate centrosome 
positioning and migration and are essential for ciliogenesis by remodeling of the actin 
cytoskeleton, indicating important roles of the nesprins during cellular and developmental 
processes. Analysis of nesprins during human muscle development revealed isoform- and 
tissue-specific roles for nesprins in nuclear positioning. Nesprin-1 knockout studies show 
that nuclear positioning and anchorage are dysfunctional in skeletal muscle from knockout 
mice. (Luke Y, et al., 2008; Dawe HR, et al., 2009; Warren DT, et al., 2010; Randles KN, et al., 
2010; Zhang J, et al., 2010; Mellad JA, et al., 2011). 
 
Most of the functions described before refer to structural roles of the nesprins. However 
nesprins are also involved in regulating signaling events across the NE or inside the nucleus. 
At the NE nesprin-2 interacts with a- and β-catenin and with emerin that has an impact on 
Wnt signaling. Inside the nucleus, nesprin-2 acts as a scaffolding protein for nuclear 
extracellular signal-regulated kinases 1 and 2 (ERK1/2, also known as MAPK1/2). A loss of 
nesprin-2 leads to sustained ERK1/2 activation and increased cell proliferation (Neumann S, 
et al., 2010; Warren DT, et al., 2010; Rashmi RN, et al., 2011; Yu J, et al., 2011) 
 
1.2.4 SUN proteins 
 
SUN proteins are type-II transmembrane proteins of the INM with an N-terminus facing the 
nucleoplasm, and a C-terminal conserved SUN domain localizing between INM and ONM. 
The eponymous SUN domain is a conversed ~200 amino acid residues spanning C-terminal 
motif that follows a trans-membrane domain and a coiled coil segment that reaches into the 
PNS. SUN proteins contain at least one transmembrane domain (Figure 1.4). The name of the 
SUN domain is derived from homologous sequences that have originally been described in 
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Schizosaccharomyces pombe Sad1 and Caenorhabditis elegans UNC-84 proteins. Later these 
sequences have additionally been found in mammalian proteins.  
 
Five SUN proteins have been identified until now: SUN1 (UNC-84A), SUN2 (UNC-84B), SUN3, 
SUN4 (SPAG4), and SUN5 (SPAG4L). To date, SUN domain proteins have been described in 
several species, such as mus musculus, Caenorhabditis elegans, Drosophila melanogaster 
(Klaroid and Giacomo), Schizosaccharomyces pombe (Sad1) and Saccharomyces cerevisiae 
(Mps3). SUN domain proteins also been reported in plants such as Arabidopsis thaliana 
(Shao X, et al., 1999; Tzur YB, et al., 2006; Hiraoka Y and Dernburg AF, 2009; Graumann K, et 
al., 2010; Jiang XZ, et al., 2010; Rothballer A, et al., 2013). 
 
SUN proteins play important roles in a wide range of cellular processes. SUN1 and SUN2 
double knockout mice die shortly after birth due to a breath system defect, suggesting that 
SUN proteins are essential. SUN1 specifically associates with telomeres during meiosis.  
Studies on SUN1-deficient mice indicate that disruption of SUN1 in mice prevents telomere 
attachment to the nuclear envelope and meiosis. As the critical processes of maintaining 
genomic stability, DNA damage response and DNA repair were described to be regulated by 
SUN proteins according their interactions with DNA-dependent protein kinase, a protein 
known to function in DNA repair. Based on the SUN1 and SUN2 double knockout mice 
research, embryonic fibroblasts displayed premature proliferation arrest in S phase of cell 
cycle, increased apoptosis and DNA damage, and decreased perinuclear heterochromatin. 
Mps3, a SUN protein found in yeast, has been described to play a role in the repair of DNA 
double strand breaks, indicating that SUN proteins have a role in maintaining genome 
stability. Studies on LMNA null or progeroid LMNA∆9 mutant mice described SUN1 
abnormally accumulated at the Golgi. Furthermore, it has been described that high levels of 
SUN proteins at the NE in lamin A mutant cells result in toxicity through a hyperactivity of 
the DNA damage response (Ding X, et al., 2007; Oza P, et al., 2009; Chen CY, et al., 2012; Lei 
K, et al., 2012; Star DA, 2012).  
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Figure 1.4 Basic structures of SUN proteins.  
Main structural characteristics shared by SUN proteins are the SUN domain (orange), and at least one trans-
membrane region (red) that mediates the anchorage to the NE. The SUN domain localizes in the lumen 
between the INM and ONM, where it interacts with the KASH domain of the nesprins (Rothballer A et al., 
2013). 
 
1.2.5 Cellular functions of the LINC complex 
 
As the core components of the LINC complex, KASH domain proteins nesprins are anchored 
along both ONM and INM through the interaction of the KASH domain with the SUN domain 
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of the SUN proteins in the PNS. Based on the localization between cytoplasm and 
nucleoplasm LINC complex components interact with proteins from both compartments. 
INM nesprins and SUN proteins interact with NE proteins like emerin and lamin A/C. ONM 
nesprins directly or indirectly interact with all cytoskeletal systems of a cell. 
 
As a linker of nucleoskeleton and cytoskeleton, the LINC complex plays an important role in 
many crucial cellular processes. The LINC complex and LINC complex-associated proteins 
form an essential connection between the cytoskeleton and the nucleoskeleton that is 
critical for intracellular force transmission and transfer of mechanical induced signals across 
the NE. Additionally, studies on the nesprin-4 and SUN1 KO mice revealed that mice lacking 
either nesprin-4 or SUN1 show  hair cell defects and hearing impairments, that 
demonstrated the LINC complex is essential for hearing (Razafsky D, et al., 2009; Méjat A 
and Misteli T, 2010; Lombardi ML, et al., 2011; Horn HF, et al., 2013). 
 
 
1.2.6 Nuclear lamins  
 
Lamins are type V intermediate filaments proteins that form a meshwork that lines the 
nucleoplasmic surface of the INM. 
 
They are grouped into A- and B-type lamins. A-type lamins include lamin A, A∆10, C and C2 
that are encoded by LMNA and formed by alternative splicing and posttranslational 
modifications. Lamin A and C are the major components of the nuclear lamina. B-type lamins 
are encoded by LMNB1 (lamin B1) and LMNB2 (lamin B2 and B3) (Worman HJ and Bonne G, 
2007). 
 
1.2.5.1 Lamins assemble to form a meshwork along the INM 
 
Basic structural aspects of mammalian lamins are the tripartite organization into an N-
terminal head domain, a central α-helical rod domain and a C-terminal globular tail domain. 
The C-terminal domain contains a structural Ig-fold and a nuclear localization signal (NLS), 
and in most cases contains a carboxy-terminal CAAX box (except lamin C). After four post-
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translational processing steps for pre-lamin A, the farnesylation of a carboxyl-terminal 
cysteine, release of the last three amino acids –AAX of the protein, methylation of the 
farnesylcysteine, and the endoproteolytic release of the carboxyl-terminal 15 amino acids of 
the protein, the mature lamin A protein is generated (Figure 1.5).  
 
 
 
Figure 1.5 Schemes summarizing structures and processing of lamins.  
(A) Main structural components of pre-lamin A are the globular N-terminal head domain, a central α-helical rod 
domain and a C-terminal globular tail domain with a carboxy-terminal CAAX motive.  
(B) Summary of post-translational processing of the pre-lamins A, B1 and B2. After four post-translational 
processing steps namely farnesylation of a carboxyl-terminal cysteine, release of the last three amino acids of 
the protein, methylation of the farnesylcysteine, and the endoproteolytic release of the carboxyl-terminal 15 
amino acids of the protein, the mature lamin A protein is generated. In lamin B1 and B2 maturation ends with 
the methylation of the C-terminal cysteine and does not include the cleavage of the C-terminal 15 residues. 
(C) C-terminal structures of mature lamins. The indicated amino acid positions are: start of the tail domain, first 
residue of the NLS, Ig-fold and most C-terminal residue of mature lamins (Dechat, et al., 2008). 
 
For the formation of higher order structures (Figure 1.6), initially two lamin polypeptides 
(about 55nm) assemble to form parallel head to tail dimer, which is driven by coiled-coil 
formation to a two stranded α-helical coiled-coil structure (around 48 nm from tail to tail). 
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Dimers then assemble into head-to-tail polar polymers, which require an overlapping 
interaction between the head and tail domains. Higher order structure is achieved by anti-
parallel, side-by-side association of polymers, the proto-filaments that underlay the NE 
(Stuurman N, et al., 1998; Prokocimer M, et al., 2009; Ho CY and Lammerding J., 2012). 
 
 
 
Figure 1.6 Assembly of lamins into filaments.  
Initially two lamin monomers assemble along their central alpha helical rod domain to form a parallel head to 
tail dimer. Following, lamin dimers assemble into head to tail polar polymers based on overlapping interactions 
between head and tail domains. Polymers then laterally assemble anti-parallel into non-polar filaments that 
form a meshwork underlying the inner surface of the INM (Ho CY and Lammerding J., 2012). 
 
1.2.5.2 Functions of lamins 
 
Nuclear lamins were identified more than 30 years ago. At the early stage of research on 
lamins, they were described as nuclear matrix components, fulfilling structural functions 
such as maintaining shape and mechanical stability of the nucleus. Along with research 
progress, it became increasingly evident that lamina proteins are involved in basic cellular 
processes such as maintaining nuclear shape and mechanical stability, as well as regulating 
gene expression, signaling pathways and functional chromatin organization. Lamin functions 
have additionally been shown to play a role in mitosis, DNA replication and repair and 
transcription (Dechat T, et al., 2010; Dittmer TA and Misteli T, 2011; Gerace L and Huber MD, 
2012; Worman HJ, 2012). 
 
 Introduction  
14 
 
 
 
Figure 1.7 Interaction partners of A- and B-type lamins.   
The scheme summarizes interaction partners that have been identified for A- and B-type lamins so far including 
their interaction sites in the lamin proteins. The interaction partners reflect the wide range of lamin functions 
along the NE and in organizing chromosomal structures as well as regulating gene expression. The majority of 
interactions have been shown for A-type lamins (Ho CY and Lammerding J., 2012). 
 
The wide range of cellular functions in which lamins have been shown to play a role, is 
reflected by the large and constantly increasing number of interaction partners that have 
been described, especial for A-type lamins (Figure 1.7). The currently described interaction 
partners include nuclear membrane associated proteins such as nesprin-2 and emerin.  
Lamins interact with chromosomal structures through interactions with histones or direct 
binding to DNA. They additionally interact with transcriptional regulators like sterol 
regulatory element-binding protein 1 (SREBP1) and ZNF239 (zinc finger transcription factor 
proteins, also known as MOK2) (Wilson KL and Foisner R, 2010; Ho CY and Lammerding J., 
2012).  
 
1.3 The LINC complex in human diseases 
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Several hundred mutations in NE proteins have been described that can result in a variety of 
human diseases such as Hutchinson-Gilford progeria syndrome (HGPS), Emery-Dreifuss 
muscular dystrophy (EDMD), Dunnigan-type familial partial lipodystrophy (FPLD), and 
cardiomyopathy that are collectively known as nuclear envelopathies. Due to the large 
number of mutations in the LMNA, the gene encoding for A-type lamins, these diseases are 
also known as laminopathies (Table 1.1). 
 
Human diseases Associated mutated gene References 
Emery-Dreifuss muscular dystrophy 
Cerebellar ataxia 
Arthrogryposis 
SYNE, encoding nesprins  Zhang Q, et al., 2007 
Gros-Louis F, et al., 2007 
Attali R, et al., 2009 
Duchenne muscular dystrophy 
Emery-Dreifuss muscular dystrophy 
Charcot-Marie-Tooth syndrome 
SUN, encoding SUN 
domain proteins 
Taranum S., et al., 2012 
Emery-Dreifuss muscular dystrophy  EMD, encoding emerin Bione S, et al., 1994 
Bione S, et al., 1995 
Hutchinson-Gilford progeria  
Emery-Dreifuss muscular dystrophy 
Familial partial lipodystrophy 
Dilated cardiomyopathy 
Charcot-Marie-Tooth disease 
Mandibuloacral dysplasia 
LMNA, encoding A-type 
lamins 
DeBusk FL, 1972 
Wessely R, et al., 2005 
Garg A, 2004 
Olson TM and Keating MT, 1996 
Bouhouche A, et al., 1999 
Garavelli L., et al., 2009 
 
Table 1.1 LINC complexes proteins and human diseases.  
The table summarizes examples of mutations in NE genes and the resulting diseases. Most of them belong to a 
group of human diseases collectively known as laminopathies.   
 
The first identified LINC complex component associated with human diseases was emerin. As 
a component of the NE, emerin interacts with several proteins at the inner and outer surface 
of the NE. These proteins are involved in regulating the activity of certain genes, controlling 
the cell cycle and maintaining the structure and stability of the nucleus. Emerin and related 
proteins also play a role in assembling the nucleus during cell division. Mutations in EMD, 
encoding for emerin, lead to an X-linked form of Emery-Dreifuss muscular dystrophy (XL-
EDMD). More than 400 different mutations (Figure 1.8) have been identified in LMNA so far 
(www.umd.be/LMNA/). Only a few mutations have been identified in B-type lamins. 
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Mutations in nesprin-1/2 and SUN proteins have also been implicated in the formation of 
laminopathies like EDMD. Mutations in nesprin-1 and -2 additionally result in disorders 
which are not characterized by NE defects such as autosomal recessive cerebellar ataxia. 
Along with research insight, more and more genes encoding NE components have been 
associated with human diseases (Bione S, et al., 1994; Cao H, et al., 2000; Vergnes L, et al., 
2004; Méjat A and Misteli T, 2010; Worman HJ, et al., 2010; Meinke P, et al., 2011; Lombardi 
ML, et al., 2011). 
 
To date, at least 15 different diseases have been linked to mutations in NE proteins like 
lamins, emerin, nesprins and SUN proteins. However, due to partially overlapping clinical 
manifestations the exact number of disease phenotypes may differ. Laminopathies range 
from skeletal muscle dystrophies to cardiac defects, metabolic diseases, diseases affecting 
the nervous system or diseases associated with early aging. Most laminopathies have a 
postnatal onset and are progressively developing during childhood or adolescence. 
Currently, there is no cure for laminopathies and treatment is symptomatic and supportive, 
without treatment some laminopathies may lead to early death. It is still not clear how 
mutations in NE proteins result in phenotypically different laminopathies with tissue-specific 
pathologies, especially when considering that most NE proteins such as lamins, are 
expressed in almost all differentiated somatic cell types. Currently, three mutually non-
exclusive hypotheses have been postulated. The first one is the structural hypothesis that 
focusses on the role of NE proteins in maintaining nuclear integrity. Mutations in NE proteins 
lead to structural weakness, and decreased ability of nuclei to maintain 
mechanotransduction along LINC complexes or to resist high mechanical strain. The second 
hypothesis is the gene-expression hypothesis, which refers to the role of NE proteins like 
nesprins or lamins in regulating gene expression. The third hypothesis, refers to the 
pathological impact of accumulated mutated NE proteins and their resulting cell toxic 
functions (Lammerding J, et al., 2004; Capanni C, et al., 2005; Columbaro M, et al., 2005; 
Markiewicz E, et al., 2006; Kandert S, et al., 2007; Furukawa K, et al., 2009; Brosig M, et al., 
2010; Dubinska-Magiera M, et al., 2012; Simon DN and Wilson KL., 2013).   
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Figure 1.8 Summary of laminopathy causing mutations in human lamin A . 
The scheme summarizes mutations in lamin A and the resulting laminopathies are classified with a colour code. 
Mutations shown in red affect skeletal or cardiac muscles. Mutations shown in blue lead to lipodystrophies, 
brown refers to neuropathies, green to systemic laminopathies and mutations in purple belong to premature 
aging disorders (Dittmer T and Misteli T, 2011).  
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1.4 Aim of the study 
 
LINC complexes connect the nucleoskeleton to the cytoskeleton by interactions among LINC 
complex proteins and their interactions to proteins in the nucleus and the cytosol. LINC 
complexes reside along the interface between cytoplasm and nucleoplasm and they are 
involved in regulating many cellular functions including maintenance of the structural 
integrity of nucleus and cytoskeleton or proper signal transduction across the NE. Mutations 
in LINC complex components have been described in a wide range of human diseases that 
include muscle diseases, metabolic syndromes neuropathies or premature ageing diseases 
that are collectively known as laminopathies. For this reason it is of particular importance to 
have a detailed knowledge about LINC complex interactions. 
 
The aim of my thesis is to further characterize interactions among LINC complex components 
and to study the pathological role of distinct mutations in these proteins. Nesprins interact 
with the INM proteins lamin A/C. The binding site between nesprin-1, -2 and lamin A/C have 
been mapped near their C-termini (Mislow JM, et al., 2002; Libotte T, et al., 2005). One aim 
of my project is to further narrow down the binding site between nesprin-2 and lamin A. 
Additionally we want to find out how laminopathy causing mutations in or near the binding 
sites of both proteins affect their interaction, which will help to answer the question how 
different mutations in one gene lead to the formation of phenotypically different diseases. 
 
To substantiate our knowledge about LINC complex protein assemblies I additionally 
characterize the novel interaction of SUN proteins to the microtubule network under normal 
or laminopathic conditions. The studies on SUN proteins include the characterization of the 
SUN1 mutation Q93P and T33A in SUN2 and their impact on NE protein assemblies. 
 
Laminopathies include early ageing diseases like HGPS that resembles aspects of ageing at an 
early age, for this reason the expression of lamin proteins in the context of ageing nesprin-2 
giant knockout (KO) mice will be analyzed. 
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2 Results 
 
2.1 Narrowing down of binding sites between lamin A and nesprin-2 
 
As a component of the LINC complex, nesprins interact with INM proteins, like lamin A/C. 
The corresponding binding sites have been mapped near the C-terminus of nesprin-1 and 
nesprin-2 (Libotte T, et al., 2005). 
 
In order to get a better understanding of the interaction between both proteins, we further 
narrowed down the binding sites between lamin A and nesprin-2 by using His-Tag and GST 
Pull down assays. 
 
A 
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Figure 2.1 Lamin A and nesprin-2 constructs used for His-tag pull down. 
(A) Lamin A constructs used in this study. The plasmids we used cover almost the entire sequence of lamin A.  
(B) Nesprin-2 constructs used in this study. On top nesprin-2 giant is shown. The C-terminal part that is known 
to interact with lamin A is underlined. The nesprin-2 constructs we used for our binding studies include five C-
terminal spectrin repeats of nesprin-2 giant (SR52-56). 
 
2.1.1 Identification of the lamin A amino acids that mediate the binding to nesprin-2 
 
First we narrowed down the interaction site of nesprin-2-SR52-56 to lamin A. For this His-tag 
pull downs were performed by using pPET-TEV-LA (1-263), pPET-TEV-LA (264-402), pPET-
TEV-LA (345-425) and Pet24d His-TEV- (436-548) lamin A expression constructs. Proteins 
were coupled to Ni-NTA beads, incubated with lysates of COS7 cells expressing GFP-nesprin-
2-SR52-56, and analyzed by western blot. The nesprin-2-SR plasmids used in this study are 
GST-nesprin-2-SR52-56, -SR52, 53, -SR53-55 and –SR55, 56. In western blots we obtained 
signals for GFP-nesprin-2-SR52-56 in the LA 345-425 fraction (Figure 2.2 A). From this we 
conclude that the interaction site of nesprin-2-SR52-56 to lamin A lies within the lamin A 
amino acid sequence from 345 to 425. 
 
By taking a closer look at the lamin A constructs we used in the in vitro binding studies, one 
can see that there is an overlap between lamin A constructs LA 264-402 and LA 345-425. 
 Results  
21 
 
Since we did not detect GFP-nesprin-2-SR52-56 together with LA 264-402, the binding site 
for lamin A to nesprin-2 must lie within lamin A amino acid 403-425 (Figure 2.2 B). 
 
A 
 
B 
 
 
Figure 2.2 Amino acids 345-425 of human lamin A interact with GFP-nesprin2-SR52-56. 
(A) His-tag pull down experiment with His tagged lamin A proteins and GFP-tagged nesprin-2-SR52-56. GFP-
nesprin-2-SR52-56 precipitates only with LA 345-425. We did not get any signals from the other lamin A 
polypeptides (LA1-263, LA 264-402 and LA 436-548). That suggests nesprin-2 interacts with lamin A through the 
amino acids 345-425. WB: western blot, P: pellet, SPN: supernatant.  
(B) Lamin A polypeptides 264-402 and 345-425 share an overlapping sequence. Since GFP-nesprin-2-SR52-56 
precipitates with LA 345-425, but not with LA 264-402, the binding site for lamin A to nesprin-2 can be 
narrowed down to lamin A amino acid 403-425 (highlight in red). 
 
2.1.2 Identification of nesprin-2 giant amino acids that mediate the binding to lamin A 
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Next we performed His-tag pull down experiments to narrow down the binding site in 
nesprin-2 to lamin A. We used the lamin proteins LA 345-425 as positive controls, since we 
identified the binding site of GFP-nesprin-2-SR52-56 to these lamin A amino acids (Figure 
2.2). LA 264-402 was used as a negative control, because this protein fragment does not 
interact with GFP-nesprin-2-SR52-56 (Figure 2.3B). His-tagged lamin A proteins that were 
bound to Ni-NTA beads were incubated with lysates of COS7 cells expressing GFP-nesprin-2-
SR52, 53, -SR53-55, -SR55, 56 proteins, respectively (Figure 2.3 A).  
 
In western blots we detected signals for GFP-nesprin-2-SR52, 53 and GFP-nesprin-2-SR53-55. 
We did not obtain signals for GFP-nesprin-2-SR55, 56. The nesprin-2 constructs -SR52, 53 
and -SR53-55 we used in the in vitro binding studies share an overlapping sequence. We got 
signals for both polypeptides in the western blot, however the signal for nesprin-2-SR53-55 
was always very weak compare to -SR52, 53, indicating the interaction site of nesprin-2 to 
lamin A resides within the SRs 52 and 53 (Figure 2.3 B). 
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A 
 
 
B 
 
 
Figure 2.3 Nesprin-2-SR52, 53 and -SR53-55 interact with LA 345-425. 
(A) His-tag pull downs were performed with lamin A proteins LA264-402, LA 345-425 that were bound to beads 
and the GFP nesprin-2 fusion polypeptide nesprin-2-SR52-56, nesprin-2-SR52, 53, -SR53-55 and –SR55, 56. We 
got signals for nesprin-2-SR52, 53 and –SR53-55. 
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(B) Nesprin-2-SR52, 53 and -SR53-55 share an overlapping sequence and GFP immunoblotting signals for -SR53-
55 were always much weaker compared to -SR52, 53. We concluded the binding site of nesprin-2 to lamin A 
lies within nesprin-2-SR52, 53, aa 6146-6347 (underline in red). 
 
2.1.3 Nesprin-2-SR53 is sufficient to mediate the interaction to lamin A 
 
In pull down experiments we found an interactions between lamin A aa 345-425 and GFP-
nesprin-2-SR52, 53, and GFP-nesprin-2-SR53-55 (Figure 2.3). Since the signal for GFP-
nesprin-2-SR52, 53 was always much stronger compared to GFP-nesprin-2-SR53-55 we 
concluded that the nesprin-2 interaction to lamin A mainly depends on SRs 52 and 53. To 
answer the question which one of these SRs is sufficient for the interaction, GST-pull down 
experiments were performed in which GFP-LA 403-425 and GST-nesprin-2-SR52, -SR53, and -
SR52, 53 proteins were used. GST-nesprin-2-SR proteins coupled to beads were incubated 
with lysates of COS7 cells expressing GFP-LA 403-425. By western blot analysis, we obtained 
signals for GST-nesprin-2-SR53 and -SR52, 53. The signal for nesprin-2-SR53 was always 
much weaker compared to the signal of nesprin-2-SR52, 53, however this SR is sufficient to 
precipitate GFP-LA 403-425 (Figure 2.4). 
 
 
 
Figure 2.4 GFP-nesprin-2-SR53 is sufficient to mediate the interaction to LA 403-425. 
The GST-pull down experiment was performed by using lamin A proteins (GFP-LA 403-425) and GST-nesprin-2-
SR proteins (-SR52, -SR53, and -SR52, 53). GFP-LA 403-425 was precipitated by nesprin-2-SR53 and -SR52, 53. 
Nesprin-2-SR53 is sufficient for mediating the interaction between lamin A 402-425, but the signal was much 
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weaker compared to the longer fragments, indicating that additional amino acids are necessary for 
strengthening the interaction between both proteins. 
 
2.2 Study on mutations in the binding sites of nesprin-2 and lamin A 
 
2.2.1 Laminopathy causing mutations reside in the nesprin-2 binding site of lamin A 
 
Currently there is accumulating evidence that lamins and further LINC complex or NE 
proteins play roles in the formation of laminopathies. For this reason we wanted to analyze 
if mutations which have been described in laminopathies that lie within or near the binding 
sites of lamin A and nesprin-2 affect the interaction between both proteins which might 
contribute to the formation of these diseases. 
 
Many mutations in lamin A have been identified until now. Most are summarized on the 
website http://www.umd.be/LMNA/. Several mutations have been reported in or near lamin 
A aa 403-425, the binding site to nesprin-2, namely R401C (1201 C>T), G411D (1232G>A), 
G413C (1237G>T), V415I (1243G>A), R419C (1255T>C), L421P (1261T>C), R427G (1279C>G) 
and Q432X (1294C>T). These mutations are characterized by large differences in their clinical 
manifestation that include lipodystrophies or metabolic syndromes for G411D, R419C, L421P 
and skeletal or cardiac muscle dystrophies in case of R401C, G413C, V415I, R427G and 
Q432X (Vytopil M, et al., 2001; Haque WA, et al., 2003; Decaudain A, et al., 2007; Brauch 
KM, et al., 2009; Møller DV, et al., 2009; Dutour A, et al., 2011). No mutations in nesprin-2 
have been described so far that might affect the interaction to lamin A. For this reason in the 
following we focused on characterizing the described mutations afore in LMNA. 
 
Above all, we aim to analyze if changes in the binding ability between nesprin-2 and lamin A 
contribute to the formation of laminopathies. 
 
2.2.2 Generation of mutated full length or short GFP lamin A constructs  
 
The first mutation we found in the binding site between lamin A and nesprin-2 was the 
mutation L421P. cDNAs encoding WT and  mutated lamin A amino acid 403-425, that were 
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shown to interact with nesprin-2 (Figure 2.2) were cloned into GFP vectors and confirmed by 
DNA-sequencing (Figure 2.5 A) and western blot analysis (Figure 2.5 B). The predicted 
molecular weight of GFP-LA 403-425 is approximate 30 kDa and thus differs only slightly 
from GFP that has a molecular weight of approximate 27 kDa (Figure 2.5 B).  
 
A 
 
B 
 
 
Figure 2.5 Sequencing results and western blot analysis of GFP-LA 403-425 WT and -L421P.  
(A) cDNAs encoding WT or L421P mutated lamin A amino acids 403-425 were cloned into GFP vectors and 
confirmed by DNA sequencing.  WT and mutated nucleotides are highlighted by arrows. 
(B) Western blot analysis of GFP-LA 403-425 fusion proteins. The proteins were transiently expressed in COS7 
cells. Lysates were analyzed by SDS-PAGE followed by western blot with mAb K3-184-2 that confirmed the 
predicted molecular weights. 
 
During our studies further mutations in lamin A have been described including [Arg401Cys 
(1201 C>T), Gly411Asp (1232G>A), Gly413Cys (1237G>T), Val415Ile (1243G>A), Arg419Cys 
(1255T>C), Leu421Pro (1262T>C), Ar427Gly (1279C>G), Gln432X (1294C>T)]. All mutations 
reside within a region of lamin A that is encoded by LMNA exon 7 and all are point mutations 
causing single nucleotide exchanges (Figure 2.6 A and B). Seven mutations result in amino 
acid changes whereas the mutation Q432X (1294C>T) causes the formation of a premature 
stop codon and thus a shorten lamin A (Figure 2.6 C and D). All LMNA mutations were 
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inserted into GFP full length lamin A by site directed mutagenesis. The success of 
mutagenesis was confirmed by DNA sequencing (Figure 2.6 B). Additionally all GFP plasmid 
were transiently expressed in COS7 cells and lysates of these cells were analyzed by western 
blot to confirm the molecular weight of each mutated protein. The predicted molecular 
weight for GFP WT lamin A and all mutations is 100 kDa. The truncated GFP-LA Q432X 
protein has a predicted molecular weight of 76 kDa. According to DNA sequencing and 
immunoblotting, all constructs are correct (Figure 2.6). 
 
A 
 
B 
 
 
 
C 
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Figure 2.6 DNA Sequencing and western blot analysis of full length WT and mutated lamin A constructs. 
(A) Nucleotides 1198 to 1296 of human LMNA are shown. Nucleotides encoding the amino acids that interact 
with nesprin-2 are underlined. LMNA mutations analyzed in the present study are highlighted below in red. 
Similarities to the WT sequence are shown as dotted lines. 
(B) LMNA mutations shown in (A) were inserted into plasmids encoding GFP tagged full length lamin A by side 
directed mutagenesis. Sequencing confirmed the success of the mutagenesis. Mutated nucleotides are 
highlighted by an arrow in each peak diagram. 
(C) Aa residues 399 to 434 of WT lamin A are shown. The interaction site of lamin A to nesprin-2 is underlined. 
Similarities to the WT sequence are shown as dotted lines, aa changes are indicated in red. The mutation 
Q432X leads to a stop codon (X). 
(D) Western blot analysis of GFP lamin A fusion proteins. The proteins were transiently expressed in COS7 cells. 
Lysates were analyzed by SDS-PAGE followed by western blot with mAb K3-184-2 that confirmed the predicted 
molecular weights. 
 
2.2.3 The interaction site of lamin A to nesprin-2 is in a loop 
 
The lamin A mutations that we analyzed here reside between aa 401 and 432 of human 
lamin A. In an alignment one can see highly conserved residues between human and Mus 
musculus lamin A along the binding site of lamin A to nesperin-2 (Figure 2.7 A). A main aim 
of the study is to characterize the impact of these LMNA mutations on the binding capacity 
to nesprin-2. For this we addressed the question in which structural region of lamin A aa 
403-425 are located. Currently only parts of the three dimensional lamin A structure are 
available. Therefore we performed a structural prediction of human lamin A aa 351-490 that 
are part of the coil2B and C-terminal globular domain (Figure 2.7 A), by using the MULTICOM 
server and 1UFGA (C-terminal immunoglobulin like domain of mouse Lamin A), 1IFRA 
(globular tail of human Lamin A), and 2LLA (chain A of Mannose-6-phosphate/insulin-like 
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growth factor II receptor) structures from the protein data bank (PDB) as templates and 
pyMOL for presentation. 
 
A 
 
 
B 
 
 
C                   Lamin A WT                                                            Mutate lamin A 
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Figure 2.7 The interaction site of lamin A to nesprin-2 is in a loop. 
(A) An amino acid alignment was performed between human lamin A/C amino acids 351-490 and the 
corresponding sequence in human lamin B and Mus musculus lamin A. The interaction region of nesprin-2 to 
lamin A is highlighted in a green frame. Secondary structure elements are shown on top of the alignment and 
conserved residues are highlighted black, similar residues are framed.  
(B) Three dimensional structure prediction of human lamin A aa 351-490. The three dimensional structure of 
human lamin A351-490 was predicted by using multiple PDB structures as templates (1UFGA, 1IFRA, and 2LLA) 
in the MULTICOM server. The interaction region of nesprin-2 to lamin A aa 403-425 is highlighted in green. 
Lamin A mutations that lie in or near the binding site of nesprin-2 analyzed in this study are highlighted in red. 
The prediction was performed by using pyMOL v1.3.  
(C) Molecular surface properties of WT lamin A and laminopathies causing lamin A mutations lie in or near the 
binding site for nesprin-2, aa 403-425. The comparison of the surface between WT lamin A aa 403-425 and the 
mutate lamin A with the mutations analyzed in this study. Highly positive and negative charged residues are 
shown in blue and red, respectively. The positive charged groups that are lost due to mutations are highlighted 
with black arrowheads, the negative charged group lamin A mutation G411D is highlighted with red arrowhead. 
 
The lamin A interaction site aa 403-425 to nesprin-2 lies in a loop (Figure 2.7 B) that is 
located between the α helical rod domain and the globular domain at the C-terminus. The 
amino acids should therefore be accessible for interactions. Interactions among proteins 
mainly base on hydrophobic or electrostatic interactions between amino acid residues. To 
analyze the impact of amino acid exchanges caused by mutations in lamin A, analyzed here 
on the electrostatic surface properties, we additionally generated a model predicting surface 
charges from which we can say that amino acid exchanges reach from charge neutrality to 
the generation of positively or negatively charged residues (Figure 2.7 C). 
 
2.2.4 Both LA 403-425 and LA 403-425 L421P interact with nesprin-2  
 
First we focused on characterizing the lamin A mutation L421P that lies within the binding 
site of lamin A to nesprin-2. We analyzed if this mutation has an effect on the interaction 
between nesprin-2 and lamin A by performing GST-pull down experiments using GST-
nesprin-2-SR52, 53 and -SR54-56 polypeptides and lysates of COS7 cells expressing GFP-LA 
403-425 wild type or LA 403-425 L421P, respectively. 
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In GST-pull down experiments, we observed an interaction between GST-nesprin-2-SR, -
SR52, 53 and both WT GFP-LA 403-425 and GFP-LA 403-425 carrying the mutation L421P 
(Figure 2.8). That suggested that the lamin A mutation L421P does not inhibit the interaction 
with nesprin-2.  
  
 
 
Figure 2.8 Both GFP-LA 403-425 WT and L421P interact with nesprin-2-SR52-56 and -SR52, 53. 
 GST-pull down experiments of WT GFP-LA 403-425 and 403-425 L421P together with GST-nesprin-2 proteins, 
show that nesprin-2-SR52-56 and -SR52, 53 interact with WT LA 403-425 and LA 403-425 L421P. The GFP 
western blot signal observed in precipitates of nesprin-2-SR52-56 polypeptides were always very weak 
compared to the signal in nesprin-2-SR52, 53 precipitates. 
 
2.2.5 Mutations in LMNA modulate binding affinities of lamin A to nesprin-2 
 
Figure 2.8 shows that the lamin A mutation L421P does not inhibit the interaction with 
nesprin-2. However, it remains to be determined if the binding affinity of lamin A to nesprin-
2 is increased, decreased or unaffected. To address that question, following series of GST 
pull down experiments were performed. Based on the interaction study between nesprin-2 
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and lamin A (Figure 2.8) we used GST tagged nesprin-2-SR52, 53 that interacts with lamin A 
and -SR55, 56 that does not shown an interaction to nesprin-2 together with lysates of COS7 
cells expressing GFP full length WT or mutated lamin A proteins. 
 
Interestingly mutated lamin A proteins precipitated in varying amounts with GST-nesprin-2-
SR52, 53 (Figure 2.9 A, exemplified shown for lamin A mutations R419C, L421P, R427G and 
Q432X). Of special note are the lamin A mutations R401C and V415I that caused an 
enhanced binding, whereas of the mutation Q432X was precipitated less efficient by GST-
nesprin-2-SR52, 53, indicating a reduced binding. All further mutations influenced the 
interaction moderately (summarized in Figure 2.9 B). 
 
A 
 
B 
  
 
Figure 2.9 Mutations in LMNA modulate the interaction to nesprin-2.  
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(A) COS7 cells expressing WT or mutated GFP lamin A proteins were lysed and incubated with recombinant 
GST-nesprin-2-SR52, 53 proteins. The use of equal amounts of GST fusion protein was confirmed by a 
Coomassie stained SDS PAGE. GST-nesprin-2-SR55, 56 proteins were used as negative controls. After incubating 
beads bound GST-nesprin-2-SR fusion proteins with lysates of GFP lamin A expressing COS7 cells, the 
supernatants were collected and subjected to western blot analysis to confirm equal GFP protein amounts 
among the experiments.    
(B) WT and mutant GFP-LA proteins show distinct binding properties to WT GST-nesprin-2-SR52, 53. The zero 
base line represents the 100 % binding strength between WT GST-nesprin-2-SR52, 53 and GFP-LA WT. 
Deviations caused by distinct mutations in LMNA are given in percent each mutation was analyzed by four to 
seven independent experiments. 
 
2.2.6 GFP-lamin A 403-425 WT and GFP-lamin A 403-425 L421P are distributed all over the 
nuclei 
 
To study the impact of distinct mutations in lamin A on the localization of nesprin-2 and 
further NE or LINC complex components, we performed immunofluorescence studies on 
COS7 and HaCaT cells transfected with GFP-tagged lamin A, aa 403-425 that contain the 
binding site to nesprin-2 as WT or with the mutation L421P. GFP alone was used as a control. 
It has been demonstrated that lamin A L421P fibroblasts have misshapen nuclei (Decaudain 
A, et al., 2007). GFP signals we observed for cells expressing GFP lamin LA 403-425 WT or LA 
403-425 L421P showed similar distributions compared with cells expressing GFP only, all 
over and around the nucleus (Figure 2.10). Differences between the localization of 
endogenous lamin A along the NE and the accumulation of the lamin A 403-425 might be 
due to the small size of the fusion proteins. GFP-LA 403-425 WT carries only 23 amino acids 
in addition to GFP, which adds only 2 kDa to GFP.  
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A   HaCaT 
 
B   COS7 
 
 
Figure 2.10 In HaCaT and COS7 cells lamin A 403-425 WT and 403-425 L421P accumulate in the nucleus. 
Nuclei of HaCaT (A) and COS7 cells (B) transfected with GFP-tagged LA 403-425 WT or LA 403-425 L421P are 
stained with DAPI. GFP-LA 403-425 or LA 403-425 L421P signals were observed throughout and around the 
transfected cells nuclei, especially inside the nucleus, similar to GFP alone.  
Scale bar, 10μm. 
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2.2.7 Mutated full length lamin A proteins localize to the NE  
 
Since we did not observe the characteristic NE localization for the short GFP-LA 403-425 WT 
or mutated L421P proteins in HaCaT cells (Figure 2.10), we continued our localization studies 
by transiently expressing WT or mutated full length lamin A in the cells. Interestingly all full 
length lamin A proteins localized along the NE in these cells undistinguishable from WT lamin 
A. The only exception was the truncation mutation Q432X that showed a more versatile 
distribution pattern. We found cells in which the protein localized along the NE like WT 
lamin A. However we found in the majority of cells aggregates formed by GFP-LA Q432X 
(Figure 2.11).  These aggregates differed in size and amount. 
 
 
 
Figure 2.11 Mutated full length lamin A proteins localize to the nuclear envelope. 
HaCaT cells transiently transfected with plasmids encoding WT or mutated GFP-LA. DNA was stained with DAPI. 
All the mutated lamin A proteins localized along the NE, like WT lamin A. Lamin A Q432X additionally formed 
aggregates along the NE. 
 
2.2.8 The lamin A mutation Q432X modulates the localization of nesprin-2 
 
To evaluate the impact of mutated lamin A proteins on the localization of endogenous 
proteins, plasmids encoding the different full length lamin A proteins were transiently 
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expressed in HaCaT and COS7 cells. First transfected cells were stained with antibodies 
targeted against endogenous nesprin-2. 
 
Nesprin-2 was observed along the nuclear envelope in HaCaT and COS7 cells transfected 
with GFP-tagged full length WT LA and all mutant lamins (Figure 2.12 A and B).  The only 
exception was the truncation mutation Q432X (Figure 2.13 A and B). GFP-LA Q432X proteins 
showed a different distribution compare to WT lamin A and the other mutated lamins. They 
formed aggregates along the NE, in which nesprin-2 accumulates. These results indicate only 
the mutation LA Q432X affects the distributions of lamin A and nesprin-2 along the NE. 
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Figure 2.12 In HaCaT and COS7 cells, GFP-tagged WT or mutated lamin A localizes along the nuclear envelope 
without disturbing the localization of nesprin-2. 
HaCaT and COS7 cells transiently transfected with plasmids encoding WT or mutated GFP-LA were stained with 
the nesprin-2 specific antibody pAb K1 and DAPI to visualize DNA. Signals for both WT and mutated GFP lamin 
A proteins and nesprin-2 were observed along the NE in HaCaT (A) and COS7 (B) cells. That suggests the lamin A 
mutations analyzed here do not change the distribution of nesprin-2.  
Scale bar, 10 μm. 
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Figure 2.13 In HaCaT and COS7 cells, GFP-tagged lamin A Q432X localizes along the NE and forms aggregates 
that sequester nesprin-2. 
HaCaT and COS7 cells transiently transfected with plasmids encoding mutated GFP-LA Q432X were stained with 
nesprin-2 specific antibody pAb K1 and DAPI to visualize DNA. Signals for both mutated GFP-LA Q432X protein 
and nesprin-2 were observed co-localizing in aggregates along the NE in HaCaT (A) and COS7 (B) cells.  
Scale bar, 10 μm. 
 
2.2.9 The lamin A mutation Q432X affects the localizations several nuclear envelope proteins 
 
Pull down experiments show modulated binding capacities between GST-nesprin-2-SR52, 53 
and mutated full length GFP lamin A proteins (Figure 2.9). To study the impact of mutated 
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lamin A proteins on further NE proteins such as lamin B1 and emerin, immunofluorescences 
studies were performed. 
 
Lamin B1 and emerin were observed along the nuclear envelope in HaCaT cells transfected 
with WT or mutated lamin A proteins (Figure 2.14). Differences in the localization patterns 
compared to cells expressing GFP WT lamin A were only observed for the lamin A mutation 
Q432X where aggregates formed by the mutated protein sequester both emerin and lamin 
B1 (Figure 2.15). 
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Figure 2.14 In HaCaT cells, GFP-tagged WT or mutated lamin A localizes along the nuclear envelope without 
modulating the localizations of nuclear envelope proteins lamin B1 and emerin. 
HaCaT cells transiently transfected with GFP tagged WT or mutant lamin A were stained with antibodies 
targeted against lamin B1 or emerin. DNA is stained with DAPI. GFP tagged WT or mutant lamin A, emerin and 
lamin B1 localize along the nuclear envelope in HaCaT cells. These lamin A mutations do not alter the 
distributions of the NE proteins lamin B1, emerin. 
Scale bar, 10 μm. 
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Figure 2.15 In HaCaT and COS7 cells, GFP-tagged lamin A Q432X localizes along the nuclear envelope and in 
aggregates that sequester lamin B1 and emerin. 
HaCaT (A) and COS7 (B) cells were transiently transfected with plasmids encoding GFP-LA Q432X and stained 
with antibodies targeted against lamin B1 or emerin, and DAPI to visualize DNA. All proteins localized along the 
NE. Lamin B1 and emerin additionally accumulated in aggregates formed by lamin a Q432X (arrows). 
Additionally, nuclear blebs were observed in COS7 cells expressing GFP-LA Q432X (arrow heads).  
Scale bar, 10 μm. 
 
2.2.7 All lamin A mutations do not alter the localization of nuclear pore complexes 
 
NPCs are major components of the nuclear envelope and play crucial roles in NE structure 
and for example the nucleocytoplasmic transfer of proteins and RNAs. We analyzed whether 
the lamin A mutations analyzed here, which lie in or near the binding site to nesprin-2, have 
an effect on the localization of NCPs by performing immunofluorescence analysis on HaCaT 
cells that transiently expressing the corresponding mutated proteins. 
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Figure 2.16 In HaCaT cells, mutated lamin A proteins do not alter the localizations of nuclear pore complexes. 
HaCaT cells transiently expressing WT or mutated GFP-tagged LA stained with antibodies targeted against NPCs 
(red). NPCs localized along the NE in transfected cells. Aggregates formed by GFP lamin A Q432X have no 
impact on the distribution of NCPs along the NE. 
Scale bar, 10 μm. 
 
The signals of GFP lamin A and NPCs co-localized along the NE were observed in all 
transfected cells (Figure 2.16). This result suggests that the lamin A mutations focused on in 
this study, even Q432X, which sequesters several NE proteins, do not impair the even 
distribution of NPCs along the NE. 
 
2.2.8 Mutations in lamin A cause the formation of misshapen nuclei after heat exposure 
 
Laminopathies often affect tissues that are under pronounced mechanical strain like skeletal 
muscle or cardiac muscle. We exemplary explored the effect of two lamin A mutations, lamin 
A V415I and lamin A Q432X on nuclear stability in heat stress assays. These mutations were 
chosen because they exhibited significantly different binding affinities to nesprin-2 and lamin 
A Q432X showed the most aberrant nuclear distribution (Figure 2.11).  
 
For heat shock experiments WT and mutated GFP lamin A proteins were expressed in 
primary human fibroblasts and exposed to a 15 min heat shock at 42°C, followed by 
immunofluorescence and a statistical evaluation of misshapen nuclei before and after the 
heat shock. No significant changes were observed between LA WT and LA V415I before the 
heat shock (4.33 % for LA WT and 7.5 % for LA V415I). The number of misshapen nuclei in 
GFP LA Q432X transfected cells was significantly increased compared to the WT already 
before the heat shock (4.33 % in the WT compared to 10.33 % for Q432X). No significant 
changes in the number of misshapen nuclei were observed after heat shock in GFP WT LA 
expressing cells (4.33 % before and 6.8 % after heat shock). However the number of 
misshapen nuclei was increased in cells expressing LA V415I (11.33 % compared to 6.8 % in 
the WT) and strongly increased in cells expressing LA Q432X (17.33 % compared to 6.8 % in 
the WT) (Figure 2.15 B). 
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Figure 2.15 Lamin A mutations V415I and Q432X trigger the formation of misshapen nuclei after heat 
exposure. 
Primary human fibroblasts transiently expressing GFP-tagged WT, V415I or Q432X lamin A were treated with a 
15 min heat shock at 42 °C. After fixation the nuclear morphology was analyzed by immunofluorescence (A) 
and statistically evaluated (B). WT GFP-LA was used as control. Two independent experiments were performed 
and 300 nuclei were analyzed for each group. Cells expressing GFP lamin A Q432X showed significant nuclear 
deformations even before heat shock compared with cells expressing GFP WT lamin A. Both cells expressing 
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GFP lamin A V415I or Q432X showed significant changes of misshapen nuclei compared to cells expressing GFP 
WT lamin A after heat shock. Student's t-tests were performed and statistically significant changes are 
highlighted with an asterisk (P<0.01), highly significant changes are shown by two asterisks (P<0.001). 
 
2.2.9 The lamin A mutation Q432X causes alterations in the chromatin structure, and 
SREBP1/ZNF239 displacements 
 
NE proteins have functions in maintaining nuclear structure which plays an important role in 
transcriptional regulation and chromatin organization. Furthermore, lamins interact with 
numerous transcription factors such as SREBP1 and ZNF239, and NE proteins like lamins or 
nesprins interact with chromatin or numerous transcription factors (Simon DN and Wilson 
KL, 2013). 
 
To explore the impact of aggregates formed by GFP-LA Q432X on chromatin structures and 
transcription factors, cells transiently expressing GFP lamin A Q432X were stained with 
antibodies against SREBP1, ZNF239, and DNA was visualized by DAPI. At sites of strong 
aggregates the DAPI staining showed gaps indicating alterations in the chromatin structure 
(Figure 2.16 A, arrow). The opposite effect was detected for SREBP1 and ZNF239. Both were 
sequestered into large aggregates of Q432X mutated lamin A proteins (Figure 2.16 B, C, 
arrows). Taken together our data point towards an impact of the mutation Q432X on the 
topology of chromatin and transcription factor distribution. 
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Figure 2.16 Aggregates formed by lamin A Q432X cause alterations in chromatin organization, and sequester 
transcription factors SREBP1 and ZNF239. 
HaCaT cells expressing GFP-LA Q432X were stained with antibodies against SREBP1 or ZNF239. DNA was 
stained with DAPI. (A) The otherwise even DNA staining showed gaps along strong aggregates formed by lamin 
A Q432X proteins (arrow). (B) Both SREBP1 (B) and ZNF239 (C) accumulate in lamin A Q432X aggregates 
(arrows). 
Scale bar, 10 μm. 
 
2.2.10 Endogenous lamin A accumulates in GFP lamin A Q432X aggregates 
 
To analyses the impact of lamin A Q432X proteins and aggregates on the distribution of 
endogenous lamin A, immunofluorescence experiments were performed on HaCaT cells 
expressing GFP-LA Q432X protein. The epitope of the antibody that was used to detect 
endogenous lamin A resides in the C-terminus of lamin A that is missing in LA Q432X due to 
the mutation. Endogenous lamin A is sequestered into lamin A Q432X aggregates (Figure 
2.17). Furthermore, weaker lamin A signals were observed in lamin A Q432X expressing cells 
compared to un-transfected cells. 
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Figure 2.17 Endogenous lamin A co-localizes with GFP-LA Q432X.  
HaCaT cells expressing GFP-LA Q432X were stained for endogenous lamin A with an antibody. The epitope of 
this antibody resides in the C-terminus of lamin A that is missing in lamin A Q432X. Co-localizations of both 
proteins along the NE and in lamin A Q432X-aggregate were observed. Furthermore, weaker lamin A (H102) 
signals were observed in lamin A Q432X expressing cells (except the aggregates) compared to un-transfected 
cells. DNA was stained with DAPI. 
Scale bar, 10 µm. 
 
2.3 Study on mutated SUN proteins in Emery-Dreifuss muscular dystrophy/Charcot-Marie-
Tooth syndrome or Duchenne muscular dystrophy patients fibroblasts 
 
2.3.1 SUN2 interacts with tubulin  
 
To identify and study novel interaction partners of SUN2 GST-pull down experiments were 
performed in the context of a PhD work that was done earlier at our institute (Eva MV, PhD 
thesis, 2011). Interestingly Tubulin was among the potential novel interaction partners 
(Taranum S., et al., 2012). To confirm the interaction between SUN2 and Tubulin GST-pull 
down experiments were performed by using the GST tagged SUN2 N-terminus (NT) and cell 
lysates of wild type fibroblast, Emery-Dreifuss muscular dystrophy/Charcot-Marie-Tooth 
syndrome (EDMD/CMT) fibroblast or Duchenne muscular dystrophy (DMD) fibroblast. We 
observed signals for all cell types when western blotting was performed with the antibody 
against α-tubulin (Figure 2.18), which suggests that SUN2 interacts with tubulin through the 
N-terminal region in all cell lines tested. Interestingly, the signal observed form the DMD 
fibroblasts much weaker compared with other fibroblast cell lines. 
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In these experiments additionally the interaction between the N-terminus of SUN2 and 
lamin A/C was shown, demonstrating that is the interaction between both proteins is not 
disturbed in the mutant fibroblasts. This interaction has been demonstrated previously 
(Crisp M, et al., 2006). 
 
 
 
Figure 2.18 SUN2 interacts with tubulin and lamin A/C. 
GST-pull down experiments with GST-SUN2 NT protein and cell lysates from control, EDMD/CMT and DMD 
fibroblasts. The pull down was probed for lamin A/C and tubulin using mAb lamin A/C and mAb α-tubulin.  
 
2.3.2 The SUN mutations SUN1 Q93P and SUN2 T33A do not alter the localizations of 
nesprin-2, emerin and lamin B1 
 
As core components of the LINC complex, SUN proteins play essential roles in maintaining 
NE integrity and several important cellular processes. To explore the impact of the SUN 
mutations SUN1 Q93P and SUN2 T33A that were found in patients with EDMD/CMT or DMD 
on LINC complex proteins assemblies, immunofluorescence studies were performed. The 
mutagenesis plasmids GFP-hSun1 (Taranum S., et al., 2012) and Sun2-V5-His (Lu WS, et al., 
2008) were used in this study. 
 
We observed no changes with regard to the distribution pattern or abundance of nesprin-2, 
emerin and lamin B1 (Figure 2.19). The low transfection efficiency prevented us from 
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carrying out biochemical analysis which could give information on the stability of the LINC 
complex. 
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Figure 2.19 HaCaT cells expressing SUN1 Q93P or SUN2 T33A do not show alterations in the distributions of 
nesprin-2, emerin and lamin B1 along nuclear envelope. 
(A) HaCaT cells expressing GFP-SUN1 carrying the mutation Q93P were analyzed for nesprin-2, emerin and 
lamin B1 distributions by using the corresponding antibodies.  
(B) The subcellular distribution of nesprin-2, emerin and lamin B1 was analyzed in HaCaT cells expressing SUN2-
V5-His carrying the mutation T33A by using the corresponding antibodies. SUN2-V5-His was recognized using a 
V5-specific antibody. 
Scale bar, 10 µm. 
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2.4 Analysis the distribution of nesprin-2 and lamin A in ageing nesprin-2 knockout mice 
 
Laminopathies include early ageing diseases like HGPS that resembles aspects of ageing at an 
early age, for this reason the nesprin-2 giant KO mice were constructed in our lab. In this 
study, the expressions of lamin proteins in the context of ageing nesprin-2 giant KO mice 
were analyzed. 
 
To assess the distribution and expression of nesprin-2 and lamin A in ageing nesprin-2 KO 
mice (24 months), western blot was performed on mouse muscle tissues from WT and KO 
mice by using lamin A/C antibodies (Figure 2.20). The amounts of lamin A/C are similar 
between WT and KO mice according to the western blot result. Our preliminary results 
suggest nesprin-2 giant has no or limited effect on the expression of lamin A proteins in 
mouse muscle. 
 
 
 
Figure 2.20 Analysis of the expression of lamin A/C in ageing nesprin-2 knockout mice. 
Muscle tissues from nesprin-2 giant KO mice and WT mice were analyzed by WB. GAPDH was used as a loading 
control. 
 
According to the western blot analysis by using lamin A/C antibody, and GAPDH antibody as 
loading control. Our preliminary results suggest that the amounts of lamin A/C are similar in 
muscle tissues between WT and nesprin-2 giant KO ageing mice. 
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3 Discussion 
 
3.1 The binding sites between lamin A and nesprin-2 
 
As a component of the LINC complex, nesprins are part of protein assemblies including actin 
filaments, microtubules, plectin, kinesin, SUN proteins and emerin. Furthermore nesprins 
interact with the INM proteins lamin A/C. Previous data from Libotte and colleagues from 
our laboratory indicated that the corresponding binding sites between lamin A and nesprins 
resides near the C-terminus of nesprin-1 and nesprin-2, amino acid sequence 6146-6545 
corresponding to nesprin-2-SR52-54 (Libotte T, et al., 2005). To get a better understanding of 
the binding properties between both proteins, we further narrowed down the binding sites 
between lamin A and nesprin-2 to amino acids 403-425 in lamin A and amino acids 6146-
6347 in nesprin-2, that together form SR52 and SR53 (Figure 2.2 and 2.3). 
The binding site of lamin A to nesprin-2 (aa 403-425) lies between the central rod domain 
and the Ig fold of the carboxyterminal tail, including the NLS (aa 417-422), which is required 
for the localization of lamins to the nucleus (Ho CY and Lammerding J, 2012). For nesprin-2, 
the binding site to lamin A spans aa 6146-6347 which lie near the KASH domain. Nesprin-2 
giant, like other nesprin isoforms, even the small ones, are anchored to the NE by their KASH 
domains and connected to lamin A by their SRs near the C-terminal KASH domain. 
In our pull down assays, the signals for GST-nesprin-2-SR52-56 were always weak (Figure 
2.8). That might be a consequence of the low protein expression levels of nesprin-2-SR52-56, 
which is always expressed at a low amounts in E. coli. A reason for the low expression might 
be the molecular weight of about 130 kDa. Interestingly, signals we obtained for nesprin-2-
SR53 and -SR53-55 to lamin A were always weak too (Figure 2.3A and 2.4). They are not as 
strong as for nesprin-2-SR52, 53, which suggest that primarily nesprin-2-SR52, 53, not only -
SR53, or -SR53-55, play a role in the binding of nesprin-2 to lamin A. Another possible reason 
might be the folding of nesprin-2-SR protein. The amino acids that are responsible for 
mediating the interaction between both proteins might be better accessible in nesprin-2-
SR52, 53. From that we conclude that amino acids in nesprin-2-SR53 are sufficient for 
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mediating the interaction to lamin A. However additional amino acids in the neighboring SRs 
are necessary for strengthening the interaction. 
 
Previously two interaction sites in lamin A to nesprin-2 have been reported that contain 
lamin A aa 243-387 and 384-566 (Libotte T, et al., 2005). In the present study we have 
confirmed and further narrowed down the interaction site around lamin A amino acids 384-
566. The interaction site around lamin A aa 243-387 could not be confirmed, which might be 
a consequence of different experimental procedures or sterical properties of the lamin A 
peptides that were used.  
 
3.2 Laminopathies causing lamin A mutations lie in or near the binding site of nesprin-2 to 
lamin A 
 
A main aim in this project was to characterize the impact of laminopathy causing mutations 
on the interaction between lamin A and nesprin-2 and to find answers to the question how 
these mutations might contribute to the formation of phenotypically different diseases. 
Eight mutations in or near the binding site to nesprin-2 have been analyzed here. These are 
the lamin A mutations G411D, G413C, V415l, R419C, L421P, that lie within the binding site 
and R401C, R427G, Q432X that are close to the binding site between both proteins. 
Mutations in nesprin-2 have not been analyzed here. Laminopathies are rare human 
diseases and currently most laminopathy causing mutations have been mapped in LMNA 
(http://www.umd.be/LMNA/; Dittmer T and Misteli T, 2011). LMNA encodes for A-type 
lamins and compared to nesprins these proteins have already been described about 30 years 
ago (Gerace L and Blobel G, 1980). Since both proteins have overlapping functions at the 
nuclear envelope and some cases of laminopathy causing mutations in nesprins have already 
been described (Meinke P et al., 2011; Zhang Q et al., 2007), one can assume that 
accompanying to the progress in the research about laminopathies and the progress in the 
field of DNA sequencing and identification of disease causing mutations, more mutations in 
nesprins will be identified in the future. 
 
The lamin A mutation R401C was identified from the patients with EDMD (Vytopil M et al., 
2002; Capanni C et al., 2003; Dittmer TA and Misteli T, 2011), G411D (Dutour A et al., 2011) 
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and L421P (Caron M et al., 2007; Decaudain A et al., 2007) were found from the patients 
with metabolic syndrome (G411D) or lipodystrophy (L421P). The mutations G413C and 
R427G cause the formation of a striated muscle laminopathy (http://www.umd.be/LMNA/). 
V415l causes the formation of a lone atrial fibrillation (Brauch KM et al., 2009; Dittmer TA 
and Misteli T, 2011), R419C (Haque WA et al., 2003) was identified in patients with FPLD and 
Q432X (Møller DV et al., 2009) in the patients with idiopathic dilated cardiomyopathy. 
According to the affected tissues, laminopathies can be subdivided into several groups, 
ranging from muscular dystrophies to cardiomyopathies, lipodystrophies, neuropathies, 
dermopathies to progeroid syndromes. According to the affected tissues, the eight lamin A 
mutations described here can be classified into two groups, lipodystrophy and metabolic 
syndrome (G411D, R419C, L421P) and skeletal and cardiac muscular dystrophies (R401C, 
G413C, V415I, R427G, Q432X) causing mutations. 
 
The binding site of nesprin-2 to lamin A resides in the tail domain of lamin A (aa 403-425), 
between the central rod domain and Ig fold at the carboxy terminus, including the NLS. In 
this study a prediction of the three dimensional structure of human lamin A aa 351-490 was 
performed. The binding site of lamin A to nesprin-2 resides in a loop between the α-helical 
rod domain and the C-terminal globular domain of lamin A. The described mutations afore in 
lamin A cause amino acid exchanges or the formation of a premature stop codon and 
therefore a truncated protein (Q432X) (Figure 2.6).  
 
According to the side chains and biochemical properties at a physiological pH of 7.4, amino 
acids are classified into 4 groups: amino acids with electrically charged side chains (positive: 
Arg, His, Lys; negative: Asp, Glu), amino acide with polar uncharged side chains (Ser, Thr, Cys, 
Asp, Glu), amino acids with unpolar aliphatic side chain (Gly, Ala, Val, lle, Leu, Met, Pro), and 
amino acids with aromatic side chains (Phe, Trp, Tyr). Amino acids with electrically charged 
or polar uncharged side chains are classified as hydrophilic due to their ability of water 
solubility. Amino acids with hydrophobic side chain are water insoluble.  
 
Ser and Thr are phosphorylation sites in proteins, they add a negatively charged group to the 
protein and often function as a switch to control the start or stop in biochemical reactions. 
For lamin A, phosphorylation sites are enriched in the head and tail domains, with the 
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highest density between the rod domain and NLS (Maraldi NM et al., 2011; Simon DN and 
Wilson KL, 2013).  
 
The lamin A mutations analyzed in this study, do not affect phosphorylation sites, however 
they affect electric charges and thus the surface and biochemical properties of the loop that 
contains the lamin A amino acids 403-425 that interact with nesprin-2 (Figure 2.7 C). Of 
special note are the amino acid exchanges caused by the mutations R401C, G413C and 
R427G that result in a loss of positively charges along the peptide surface (Figure 2.7 C). 
Contrary to that is the mutation G411D that inserts a novel negative charge. We have 
narrowed down the interaction site between both proteins to 23 amino acids in lamin A and 
amino acids 6146-6347 in nesprin-2. These amino acids in nesprin-2 form SRs 52 and 53. We 
have additionally demonstrated that SR53 is sufficient for mediating the interaction between 
both proteins. However immunoblotting signals were always weak compared to the larger 
nesprin-2 polypeptide that spans SRs 52 and 53 (Figure 2.8). From this we conclude that 
especially on the side of nesprin-2 the amino acids that mediate the binding between both 
proteins are spread along a larger distance compared to the compact binding site of lamin A 
to nesprin-2. Crystal structure analysis of both proteins will be necessary to analyze exact 
consequence of distinct amino acid and charge changes on the interaction between both 
proteins. 
 
3.3 Mutations in LMNA modulate binding affinities of lamin A for nesprin-2 
 
Laminopathies are rare human diseases with complex genotype/phenotype relationships. It 
is particularly surprising that most of the proteins that are targets for mutations in 
laminopathies like emerin, lamin A/C or nesprins are almost ubiquitously expressed 
(Worman HJ et al., 2010). However distinct mutations in genes encoding these proteins lead 
to the formation of diseases with strong differences in their clinical manifestations (Lu W  et 
al., 2012; Taranum S et al., 2012; Worman HJ, 2012). Along the nuclear envelope nesprins 
and lamins are part of large protein assemblies and both proteins have a high number of 
cellular functions and interaction partners. These interactions include cytoskeletal or nuclear 
envelope associated proteins, transcription factors or chromatin (Hetzer MW, 2010; Ho CY 
and Lammerding J, 2012; Dubinska-Magiera M, et al., 2013). To explore if the LMNA 
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mutations analysed here have an impact on the binding capacities between both proteins 
series of GST-pull down assays were performed. Since both proteins are integrated into 
protein networks altered binding strength among certain components of these networks, for 
example between nesprin-2 and lamin A, might modulate the ability of these proteins to 
interact with other proteins and thus to fulfill their normal function in the cell. This would 
contribute to explain how different mutations in one gene lead to the formation of 
phenotypically different diseases. 
 
The first mutation that was analyzed in this work was the lamin A mutation L421P. To 
characterize the interaction between nesprin-2 and L421P mutated lamin A, pull down 
experiments were performed between GFP-LA 403-425 WT/L421P and GST tagged nesprin-
2-SR52-56 polypeptides and smaller SR polypeptides. Both the WT or mutated lamin A 
proteins with nesprin-2-SR52-56 (Figure 2.8). From that we conclude that the interaction 
between both proteins is not abolished by the mutation, even though the amino acid 
exchange from a lysine to a proline is known to cause severe structural changes, but these 
are especially known to be critical in alpha helical structures (Sakai H and Tsukihara T, 1998) 
and probably less severe in the loop that contains the lamin A binding site to nesprin-2. At 
that point it remained an open question if the binding affinity of lamin A to nesprin-2 is 
increased, decreased or unaffected. Therefore, following GST pull down experiments were 
performed between nesprin-2 and full length WT lamin A or mutated GFP lamin A, followed 
by a quantitative evaluation of the corresponding binding intensities (Figure 2.9). The 
advantage of the experimental setting that was chosen here is that we used GST-tagged 
nesprin-2 polypeptides that were bound to beads together with WT or mutated GFP lamin A 
proteins that were purified from otherwise normal cells. The COS7 cells that we used are a 
well-established laboratory cell system and they contain LINC complex components like 
nesprins, lamin A/C (Libotte T, et al., 2005). This brings the binding studies closer to normal 
cell conditions than interaction studies performed on purified lamin A/C protein and nesprin-
2 polypeptides. 
 
From the experiments one can see that the LMNA mutations R401C, G411D and V415l 
increased the binding affinity between lamin A and nesprin-2-SR proteins, oppositely the 
binding ability for mutations G413C, R419C, L421P, R427G and Q432X were decreased 
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compared to the WT lamin A /nesprin-2 interaction. Especially the mutations Q432X and 
V415l, affect the binding affinity by increasing or decreasing the binding strength about ~±50 
% (Figure 2.9).  The lamin A mutation Q432X leads to the formation of a truncated lamin 
protein (Figure 2.6). Mature human lamin A contains 646 amino acids (Dechat T, et al., 
2008). The newly formed stop code (X) result in the shorten protein (Figure 2.6 D). One 
approach to explain the reduced binding capacity between nesprin-2 and lamin A might be 
that due to the loss of the lamin A C-terminus lamin A Q432X mutated proteins might not 
properly be folded and amino acids that are necessary for the interaction are no longer 
present in the correct formation or no longer accessible. 
 
3.4 Mutated GFP lamin A proteins localize along the NE and Q432X proteins additionally 
form aggregates 
 
In binding studies we found that each mutation analyzed here has a distinct impact on the 
interaction between nesprin-2 and lamin A (Figure2.9). To address the question if such 
altered biochemical properties have consequences on their subcellular localization, 
immunofluorescence studies were performed. 
 
We started our experiments with short lamin A polypeptides that only contained the binding 
site of lamin A to nesprin-2. WT and mutated L421P lamin A aa 403-425 were analyzed by 
immunofluorescence. Similar signals were obtained among cells expressing GFP-LA 403-425 
WT, GFP-LA 403-425 L421P or cells transfected with the empty GFP vector. GFP signals were 
detectable all over the nucleus and dispersed throughout the cell (Figure 2.10). The small 
lamin polypeptides do not show the typical NE localization that is known for lamins. This 
might be because the GFP fusion proteins contained only a small part of lamin A (23 amino 
acids) and this short sequence might not be sufficient to be integrated into the lamina. In 
general lamins are characterized by a tripartite organization into an N-terminal head, a 
central alpha helical rod and a c-terminal tail. The head and tail parts play a critical role in 
lamin A assembly (Ho CY and Lammerding J, 2012). The nuclear localization of the small 
lamins might be explained due to the presence of the NLS (aa 417-422) or the ability of GFP 
alone to accumulate inside the nucleus (Figure 2.10). 
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For this reason in the following experiments full length GFP lamin A proteins were used.  
Surprisingly all lamin A mutations analyzed here localize along the NE and were thus not 
distinguishable from WT GFP lamin A (Figure 2.11). The only mutation that differed from this 
was the truncation mutation Q432X that showed a more versatile distribution pattern. GFP 
signals were detectable along the NE and additionally in aggregates that presumably occur 
along the NE rather than inside the nucleus. GFP lamin A Q432X NE signals were always very 
weak compared to the intensity of the aggregated proteins and thus NE signals are barely 
visible in IF pictures (Figure2.11, 2.15). 
 
It has not been described before that mutated Q432X lamin A proteins form aggregates, 
however the formation of aggregates has been reported for other lamin A mutations like 
D192G, N195K, M371K, R386K, R482L (Hübner S, et al., 2006; Sylvius N et al., 2008). These 
mutations localize along different positions of lamin A. From this one can conclude that 
aggregate formation in lamin A might have different reasons that reach from single amino 
acids exchanges to a truncation of the protein as it is the case for the mutation Q432X. 
 
Studies on the distributions of lamin A WT, or with the mutations G465D R482L and R527P 
suggested that 24 hours after transfection the proteins localized to the nucleus or the NE. A 
prolonged expression resulted in the formation of aggregates with varying intensities among 
mutated, even in the cells expressing WT lamin A (Bechert K, et al., 2003). The results 
observed on lamin A Q432X in this study are different. 24 hours after transfection the 
mutated protein aggregated in contrast to all other mutant or WT lamin A proteins analyzed 
here. We tried to exclude the possibility that protein aggregation is a sole consequence of 
the overexpressed protein. For this reason we tried to obtain primary cultures from   
patients. No primary cell cultures were available. 
 
3.5 The LMNA mutation Q432X alters the localizations of several nuclear envelope proteins 
 
Lamins are LINC complex components. To explore the impact of mutated lamin A on the 
subcellular distribution of further LINC complex component, immunofluorescence studies 
were performed with HaCaT and COS7 cells. These cell lines were chosen because they are 
established in the lab and they are known to differ in respect to the expression levels of 
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nesprin-2 and nuclear stability. HaCaT keratinocytes seem to have a more stable nuclear 
morphology and are thus less prone for deformation than the fibroblasts like COS7 cells 
(Kandert S, et al., 2007). 
 
First the distribution of nesprin-2 was analyzed (Figure 2.12). No differences in the 
localization of nesprin-2 along the NE were observed between cells expressing GFP WT or 
the lamin A mutations R401C, G411D, G413C, V415l, R419C, L421P and R427G. In cells 
expressing lamin A Q432X, the situation is different. Here nesprin-2 signals were observed 
along the NE and in aggregates formed by the mutated lamin A. The sequestration of 
nesprin-2 into the aggregates was especially strong in COS 7 (Figure 2.13). Since binding 
studies between nesprin-2 and lamin A show a reduced binding between both proteins in 
pull down experiments (Figure 2.9) it appears surprising that nesprin-2 is sequestered into 
these aggregates. To answer the question why nesprin-2 is nevertheless sequestered into 
the aggregates cells expressing Q432X mutates lamin A proteins were stained with 
antibodies targeted against the C-terminus of lamin A that is not present in the mutated 
lamin. These experiments showed that endogenous lamin A was present and accumulated in 
these aggregates (Figure 2.11) and might sequester nesprin-2. 
 
The impact of mutated lamin A on the localizations of further LINC complex components like 
emerin and lamin B1 was also analyzed. The result was similar to the subcellular distribution 
of nesprin-2. The only lamin A mutation that had an impact on the distribution of 
endogenous LINC complex components was Q432X. Aggregates formed by this particular 
mutation sequester lamin B1 and emerin (Figure 2.15). 
 
Mutations in lamins are rare and the number of reported cases and detailed information for 
example on the impact of the mutated proteins on further nuclear envelope proteins are 
often not available. However the mutation L421P was analyzed in more detail and it was 
found that in fibroblasts from L421P patients lamin A/C showed an intranuclear staining of 
lamins A/C and B (Decaudain A, et al., 2007). The difference between the localization of 
lamins in the nucleus of patient´s fibroblasts and along the nuclear envelope in our cell 
culture experiments with GFP lamin A L421P expressing cells might be due to the cell lines 
that were used or the expression levels between the overexpressed GFP proteins and 
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endogenous lamin A/C in fibroblasts.  For this reason we tried to expand our studies on 
primary cultures of patient´s cells, but these cells were not available. 
 
3.6 LMNA mutations do not alter NPC assemblies along the NE 
 
As a major component of the NE, NPCs play important roles in nuclear and cellular structures 
and functions. Approximate 30 Nups have been described till now, among them Nup153 and 
Nup88 have been confirmed to interact with lamin  in vitro (Al-Haboubi T, et al., 2011; Lussi 
YC, et al., 2011). Therefore, immunofluorescences were performed on HaCaT cells 
expressing WT or mutant GFP lamin A proteins and these cells were stained with a Nups 
specific antibody. The NPC antibody used for these studies specifically recognizes the 
repeated FXFG repeat sequence of Nup62, Nup152 and Nup90. Immunofluorescence 
showed that any of the mutations analyzed here changes the even distribution of NPCs along 
the NE. Of special note is the mutation lamin A Q432 that forms aggregates along the NE 
(Figure 2.16). These aggregates sequester LINC complex components like lamin A (Figure 
2.11), nesprin-2 (Figure 2.13), emerin and lamin B1 (Figure 2.15). However the distribution 
pattern of NPCs in the vicinity of Q432X aggregates was not altered (Figure 2.16).  
 
Earlier findings on mutated A type lamins showed a partially different effect. In 2006 Hübner 
and colleagues published a work about the lamin A mutations N195K and R386K (Hübner S, 
et al., 2006). Overexpressed FLAG tagged lamin A N195K and R386K proteins formed 
aggregates, comparable to those described here for lamin A Q432X. Interestingly Nup153 
was recruited into these aggregates whereas the situation was different for Nup98. The 
authors analyzed the sequestration capacity of FLAG tagged lamin A N195K and found that 
Nup98 was not recruited into the aggregates. Together these data support our findings that 
aggregates formed by mutated lamins have the ability to sequester NE proteins, however 
sequestration follows a distinct pattern and is not a generalized mechanism. 
 
3.7 The lamin A mutation Q432X causes alterations in the chromatin organization and 
SREBP1/ZNF239 misplacement 
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NE proteins such as lamins and LINC complex proteins either directly or indirectly interact 
with DNA or chromatin and play roles in chromatin organization and DNA transcription 
(Maraldi NM, et al., 2010; Wilson KL and Foisner R,2010; Ho CY and Lammerding J, 2012; 
Simon DN and Wilson KL, 2013). Lamins directly interact with DNA or histones, which are 
critical for DNA packaging and higher order organization into nucleosomes and play roles in 
gene regulation. The DNA binding site of lamins A/C was mapped to aa 411-553 (Stierlé V, et 
al., 2008) and aa 396-430 interact with histones (Taniura H, et al., 1995). In this study the 
binding sides of nesprin-2 to lamin A was narrowed down to aa 403-425. These amino acids 
reside within a loop between the central alpha helical rod and the C-terminal globular tail 
that is part of a major binding zone of lamin A interaction partners (Simon DN and Wilson KL, 
2013). Studies on the lamin A mutations causing HGPS patient cells demonstrated that the 
mutant lamin A protein causes abnormal chromatin anchorage and chromosome 
positioning. Our finding that aggregates formed by lamin A Q432X causes alterations in the 
chromatin organization (Figure 2.16 A, arrow) provide further evidence for the role of lamins 
in chromatin organization. The mutation Q432X results in the formation of a stop codon at 
position aa 432 of lamin A which leads to a loss of most of the DNA binding site (aa 411-553) 
in lamin A. Furthermore the mutation might affect the interplay between lamins and histone 
because the truncation eliminates a part of the histone interaction site (aa 396-430). Taken 
together the loss of carboxyterminal amino acids in lamin A Q432X alters the interaction to 
chromatin/DNA which might lead to the formation of the chromatin gaps (Figure 2.16 A). 
 
Recent studies more and more uncover the role of NE proteins in regulating signaling 
processes at the NE (Heessen S and Fornerod M, 2007). Both lamins and nesprins have been 
described being involved in various signaling pathways such as the Wnt/β-catenin pathway 
and MAPK signaling (mitogen-activated protein kinase) (Ivorra C, et al., 2006; Tilgner K, et al., 
2009; Neumann S, et al., 2010; Rashmi RN, et al., 2012). As a target and/or anchoring protein 
of signaling molecules, lamin A has been demonstrated to interact with transcription factors 
like SREBP1 and ZNF239 (Dreuillet C, et al., 2002; Lloyd DJ, et al., 2002) and play roles in 
regulating the subcellular distribution localizations of both SREBP1 and ZNF239 (Dreuillet C, 
et al., 2008; Duband-Goulet I, et al., 2011). The interaction site of lamin A to ZNF239 was 
mapped to lamin A aa 243-387 (Dreuillet C, et al., 2002) and aa 389-664 interact with 
SREBP1 (Lloyd DJ, et al., 2002). Theses sides include the lamin A binding site to nesprin-2, aa 
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403-425. The lamin A mutation Q432X induced lamin A protein aggregates along NE that 
sequester LINC complex components. To further explore the pathological role of this 
mutation, we analyzed the impact of the mutated proteins on the subcellular distribution of 
the transcription factors SREBP1 and ZNF239. Both SREBP1 and ZNF239 were sequestered 
into the lamin A Q432X aggregates in cells expressing GFP lamin A Q432X, which suggested 
the mutation Q432X affects the subcellular distributions of both SREBP1 and ZNF239.  
 
SREBP1 is an ubiquitously expressed transcription factors with functions in a wide range of 
cellular processes including cholesterol and fatty acid metabolism or the regulation of 
muscle size and protein content (Horton JD, et al., 2002; Dessalle K, et al., 2012). In muscle 
they regulate the expression of proteins involved in controlling contractility like Titin and 
Troponins (Lecomte V, et al., 2010; Dessalle K, et al., 2012). SREBP1 attaches to the ER 
membrane and the NE as an inactive precursor. Cleavage of the SREBP1 precursor is initiated 
by sterol deficiency that releases the N-terminal part as a mature protein from the 
membrane that is translocate into the nucleus where it binds to the sterol regulatory 
element-1 DNA sequence in the promoter region of target genes (Wang X, et al., 1993; 
1994). Malfunctions in SREBP1 target genes have been described result in the formation of 
dilated cardiomyopathies (Harvey PA and Leinwand LA, 2011; Herman DS et al., 2012).  
 
ZNF239 proteins are transcription factors able to recognize both DNA and RNA through their 
zinc finger motifs and involved in transcription and post-transcriptional regulation of their 
target genes. The lamin A mutation Q432X results in lamin A aggregates that sequester 
ZNF239, which may deregulate ZNF239 activity and thus alter the expression of target genes. 
Dreuillet C and his colleagues observed similar aggregates of mutant lamin A proteins, and 
aberrant cellular localization of ZNF239 induced by A type lamins mutations such as ∆K261, 
R249Q, Q294P and R377H (Dreuillet C, et al., 2008). 
 
It remains an open question if mutated lamin A Q432X in patient´s cells shows similar 
characteristics like the ectopically overexpressed GFL lamin A protein analyzed here and if 
the transcription factors ZNF239 and SREBP1 are sequestered as well in these cells. If they 
are sequestered transcriptomics will help to identify the expression profiles and identify 
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cellular malfunctions that lead to the formation of idiopathic dilated cardiomyopathy that is 
caused by the lamin A mutation Q432X.     
 
3.8 Study on mutated SUN proteins in Emery-Dreifuss muscular dystrophy/Charcot-Marie-
Tooth syndrome or Duchenne muscular dystrophy patients’ fibroblasts 
 
In the context of a PhD project that was done earlier at our institute potential SUN2 
interaction partners were identified in WT fibroblast and in fibroblasts from DMD or 
EDMD/CMT patients (Eva-Mawina Vaylann, Interactions and subcellular distribution of 
human SUN2. 2011). In DMD patients a mutation in DMD was identified. For the EDMD/CMT 
patient no mutation in classical candidate genes (STA, LMNA and FHL1) was identified. 
However, both harbored mutations in nesprin-1 or SUN1/2, respectively (Taranum S, et al., 
2012). The DMD patient had a mutation in the 5´UTR present in nesprin-1α2. Additionally 
the SUN1 mutation c.278A>C, p.Q93P was identified. For the EDMD/CMT patient the 
nesprin-1α1 mutation p.N323H was identified in addition to the SUN2 mutation c.97A>G, 
p.T33A. For both patients the nesprin mutations were defined as primarily not pathogenic. 
For this reason the following studies were focused on the SUN mutations. 
 
In the context of this project tubulin was identified as a potential novel SUN2 interaction 
partner. The GST-pull down experiments that were performed in this study confirmed the 
interaction between the GST-SUN2-NT and tubulin in control and EDMD/CMT, DMD cell 
lysates. The tubulin immunoblotting signal was always strongly reduced in the DMD patient 
compared to the WT control or the EDMD/CMT patient, indicating a disturbed interaction or 
protein network in these cells. SUN proteins are INM proteins and tubulin localizes 
throughout the cytoplasm and is involved in cellular processes like mitosis and meiosis (Chen 
JG, et al., 2003). Based to the presence in different cellular compartments, SUN2 along the 
INM and tubulin in the cytoplasm, we proposed that the interaction between SUN2 and 
tubulin might happen in cell division during nuclear envelope breakdown. It has been 
described that SUN proteins co-localize with condensed chromosomes in mitosis and play 
roles in in neurogenesis and neuronal migration and DNA damage response (Eva-Mawina 
Vaylann, Interactions and subcellular distribution of human SUN2. 2011; Zhang X, et al., 
2009; Lei K, et al., 2012). However, it is not clear how SUN proteins are involved in mitosis. 
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Together with our results, we proposed that SUN proteins and tubulin might play a role in 
cell proliferation.  
 
To further study the pathological role of the SUN1/2 mutations on nuclear envelope protein 
assemblies, additional immunofluorescence studies were performed. These studies were 
performed with HaCaT cells transiently expressing SUN1 Q93P or SUN2 T33A constructs. 
However, we did not identify obvious changes in the subcellular distribution of nesprin-2, 
emerin and lamin B1 (Figure 2.19). These results were similar to the ones observed for the 
lamin A mutations R401C G411D, G413C, V415l, R419C, L421P and R427G, where no 
difference s in the localization of LINC complex components were detected under normal cell 
culture conditions (Figure 2.12, 2.14). However we cannot exclude that the mutations 
analyzed here affect the assembly of LINC complexes. For the lamin A mutations analyzed 
here we identified that each mutation has a distinct impact on the interaction to nesprin-2 
(Figure 2.9). These modified interactions might lead to enhanced or decreased interactions 
among NE proteins. Since NE proteins are always present in large protein complexes, altered 
interactions among certain components might have consequences on the ability of the 
proteins to interact with further interaction partners and to fulfill their cellular functions. 
Further studies will be necessary to unravel the pathological role of the SUN mutations 
described here. 
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4 Materials and Methods 
4.1 Plasmid constructs 
4.1.1 Cloning strategies 
 
The amino acid positions of nesprin-2 proteins refer to nesprin-2 giant (Swiss-Prot: 
Q8WXH0.3). GFP-nesprin-2-SR/-SR1+2/-SR2+3/-SR3+4, pGEX-4T-1-nesprin-2-SR/-SR1/-SR2/-
SR1+2/-SR3+4 (Libotte T., et al., 2005, Neumann S, et al., 2010), pGEX-4T-1-SUN2-NT, SUN2-
V5 His T33A and GFP-hSUN1 Q93P (Lu W, et al., 2008; Taranum S., et al., 2012) were 
generated in our lab before. pPET-TEV-LA (aa 1-263), pPET-TEV-LA (aa 264-402), pPET-TEV-
LA (aa 345-425) and Pet24d His-TEV-(aa 436-548) expression constructs are kind gifts from 
Larisa Kapinos (Kapinos LE, et al., 2010 ). The binding site of lamin A to nesprin-2, amino 
acids 403-425 (NCBI Reference Sequence: NM_170707) were cloned into the pEGFP-C2 
vector (Clontech) by using EcoR I and BamH I restriction sites and the following primers: 
LA 403-425 WT 
Forward: 5’ 
AATTTCCTCTCACTCATCCCAGACACAGGGTGGGGGCAGCGTCACCAAAAAGCGCAAACTGGAGTCC
ACTGAG 3’ 
Reverse: 5’ 
GATCCTCAGTGGACTCCAGTTTGCGCTTTTTGGTGACGCTGCCCCCACCCTGTGTCTGGGATGAGTGA
GAGGA 3’  
 
For LA 403-425 L421P, the mutation L421P (1262T>C) was introduced into pEGFP-C2-LA 403-
425 WT by QuickChange site directed mutagenesis (Stratagene) according to the 
manufacturer’s instructions, by using the following primers: 
Forward: 5’ CCAAAAAGCGCAAACCGGAGTCCACTGAG 3’ 
Reverse: 5’ CTCAGTGGACTCCGGTTTGCGCTTTTTGG 3’ 
 
Full length lamin A mutations R401C (1201C>T), G411D (1232G>A), G413C (1237G>T), V415I 
(1243G>A), R419C (1255C>T), L421P (1262T>C), R427G (1279C>G) and Q432X (1294C>T) 
were introduced into pEGFP-C2-LA (Broers JL, et al., 1999)  by QuickChange site directed 
mutagenesis with the following primers: 
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LA R401C (1201C>T) 
Forward: 5’ CCTCGCAGCGCAGCCGTGGCTGTGCTTCCTCTCACTCATCC 3’ 
Reverse: 5’ GGATGAGTGAGAGGAAGCACAGCCACGGCTGCGCTGCGAGG 3’ 
LA G411D (1232G>A) 
Forward: 5’ CTCATCCCAGACACAGGATGGGGGCAGCGTCACC 3’ 
Reverse: 5’ GGTGACGCTGCCCCCATCCTGTGTCTGGGATGAG 3’ 
LA G413C (1237G>T) 
Forward: 5’ CCCAGACACAGGGTGGGTGCAGCGTCACCAAAAAG 3’ 
Reverse: 5’ CTTTTTGGTGACGCTGCACCCACCCTGTGTCTGGG 3’ 
LA V415I (1243G>A) 
Forward: 5’ CCAGACACAGGGTGGGGGCAGCATCACCAAAAAGCGCAAACTGG 3’ 
Reverse: 5’ CCAGTTTGCGCTTTTTGGTGATGCTGCCCCCACCCTGTGTCTGG 3’ 
LA R419C (1255C>T) 
Forward: 5’ GGCAGCGTCACCAAAAAGTGCAAACTGGAGTCCACTG 3’ 
Reverse: 5’ CAGTGGACTCCAGTTTGCACTTTTTGGTGACGCTGCC 3’ 
LA L421P (1262T>C) 
Forward: 5’ CACCAAAAAGCGCAAACCGGAGTCCACTGAGAGCC 3’ 
Reverse: 5’ GGCTCTCAGTGGACTCCGGTTTGCGCTTTTTGGTG 3’ 
LA R427G (1279C>G) 
Forward: 5’ CTGGAGTCCACTGAGAGCGGCAGCAGCTTCTCACAGC 3’ 
Reverse: 5’ GCTGTGAGAAGCTGCTGCCGCTCTCAGTGGACTCCAG 3’ 
LA Q432X (1294C>T) 
Forward: 5’ GAGCCGCAGCAGCTTCTCATAGCACGCACGCACTAGCGG 3’ 
Reverse: 5’ CCGCTAGTGCGTGCGTGCTATGAGAAGCTGCTGCGGCTC 3’ 
 
4.1.2 Mini/Midi-preparation DNA assays 
 
After site directed mutagenesis, PCR products were first analyzed on 0.8 % agarose gel (w/v). 
Plasmids running on the size of around 6.7k bp were confirmed by DNA-sequencing. Correct 
clones were transformed into competent E.coli XL1 blue. For the purpose bacteria were 
thawed on ice for 5 min. Afterwards 2 ng plasmid DNA were added to a solution of 100 μl 
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competent bacteria and incubated at 4 °C for 15 min. The mixture was exposed to a heat-
shock at 42 °C for 90 sec followed by an incubation at 4 °C for 2 min. 1 ml SOC-medium (2 % 
Bacto-Trypton (w/v), 0.5 % Yeast extract (w/v), 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 
mM MgSO4 and 20 mM Glucose) was added followed by an incubation in a shaker for 1 h at 
37 °C. Afterwards the bacteria were centrifuged at 6.000 rpm for 10 min and pellets were 
dissolved in a minimum amount of LB medium to completely transfer them onto an agarose 
plate staggered with the corresponding antibiotic. The plates were incubated o/n at 37 °C. 
Single clones were selected and incubated with 5 ml LB medium (1 % Bacto-Trypton (w/v), 
0.5 % Yeast extract (w/v), 0.5 % NaCl (w/v)) supplemented with the corresponding antibiotic 
o/n.  
2 ml of the o/n cultures were centrifuged for 2 min at 6.000 rpm, and the pellets was re-
suspended in 300 μl re-suspension buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 100 μg/ml 
RNAse), followed by a 3 min incubation in 300 μl lysis buffer (0.2 N NaOH, 1 % SDS (w/v)) 
that was added by gently mixing. Finally the reaction was stopped by adding 300 μl stop 
buffer (3 M KAc, pH 5.5) and a centrifugation at 12.000 rpm for 20 min. Each supernatant 
was carefully transferred into a fresh 1.5 ml reaction tube without transferring proteins that 
appear as white flakes in the solution. Plasmid DNA was precipitated by the addition of 0.8 
ml isopropanol and a centrifugation at 14.000 rpm for 20 min. The pellet was additionally 
washed with 200 μl 70 % ethanol (v/v) and dried on air. Finally the DNA plasmid was re-
suspended in 100 μl 5 mM Tris-HCl, pH 8.0 and heated at 65 °C for 10 min to destroyed 
DNAses. DNA sequencing was performed to confirm the success of the site directed 
mutagenesis. The following primers were used for the sequencing of GFP full length lamin A 
plasmids. Nucleotide positions refer to the WT LA (NCBI Reference Sequence: 
NM_170707.3). 
WT LA, Nucleotides: 342-363 
Forward:  5’ GGAGCTGAAAGCGCGCAATACC 3’ 
WT LA, Nucleotides: 768-790 
Forward:  5’ GGAGCAGTATAAGAAGGAGCTGG 3’ 
WT LA, Nucleotides: 1080-1102 
Forward:  5’ GGAGCTTCTGGACATCAAGCTGG 3’ 
WT LA, Nucleotides: 1672-1693 
Forward:  5’ GGAGATGACCTGCTCCATCACC 3’ 
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Plasmid DNA for transfection was extracted from bacteria by using the PureYield Plasmid 
Midi-prep System Kit (Promega) according to the standard DNA purification protocol. 
 
4.2 Cell culture and transfections 
 
All cells lines (Table 4.1) used here were cultured in incubators at 37 °C in a humidified 
atmosphere with 5 % CO2. COS7, HaCaT and human primary fibroblast were grown in 
Dulbecco’s modified Eagle’s medium (DMEM, PAA) supplemented with 10 % fetal bovine 
serum (FBS, w/v), 1 % penicillin-streptomycin (v/v) and 2 mM L-glutamine. Fibroblasts from 
patients with duchenne muscular dystrophy (DMD) or Emery-Dreifuss muscular 
dystrophy/Charcot-Marie-Tooth syndrome (EDMD/CMT) were grown in Minimum Essential 
Medium (MEM, GIBCO) supplemented with 20 % fetal calf serum (FCS, w/v), 1 % penicillin-
streptomycin (v/v) and 2 mM L-glutamine. COS7 cells were transfected by using Gene-
Pulser-II (Bio-Rad) at 180 V and 950 microfarads. HaCaT cells (program: U-020) and 
fibroblasts (program: A-014) were transfected using the Amaxa cell line Nucleofector-kit V 
(Lonza) according to the manufacturer’s instructions. 
 
Cell line Species Tissue Resource 
COS7 Cercopithecus aethiops African green monkey 
kidney  
Gluzman Y., 1981 
HaCaT Homo sapiens Human keratinocytes Boukamp P., et al., 1988 
Primary human 
fibroblast 
Homo sapiens Human foreskin Lu W, et al., 2012 
DMD Homo sapiens Human primary 
fibroblasts 
Zhang Q, et al., 2007 
EDMD/CMT Homo sapiens Human primary 
fibroblasts 
Zhang Q, et al., 2007 
 
Table 4.1 Cell lines used in this study.  
The table summarizes the cell lines that were used in this study, including information about species, tissue and 
literature reference. 
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4.3 In vitro pull-down assays 
4.3.1 Protein lysates from cells 
 
COS7 cells expressing GFP-tagged proteins, or primary human fibroblast were trypsinized 
and the pellets were resuspended in 1 ml lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 
1 % Nonidet-P 40 (w/v), and 0.5 % sodium deoxycholate (SDS, w/v)) supplemented with 
protease inhibitors (1 x proteinase inhibitor cocktail (Sigma), 1 mM DL-Dithiothreitol (DTT), 1 
mM benzamidine, and 1 mM Phenylmethanesulfonyl fluoride (PMSF)). In the next step the 
cell suspension was pushed and pulled six times through a needle (0.4 × 19mm) followed by 
an incubation at 4 °C for 15 min. Following the suspension was sonicated for 2 min (35 % 
amplitude, Hielscher Ultrasonics) and centrifuged at 16.000 rpm for 30 min at 4 °C. 
Supernatants were separated from the pellets and used in the following experiments. 
 
4.3.2 His-tag pull-down and GST pull-down 
 
Plasmids encoding His- or GST-tagged proteins were transformed into the bacterial strain 
E.coli XL1 blue, and protein production was initiated by the addition of 0.5 mM Isopropyl-1-
thio-D-galactopyranoside (IPTG) o/n at 20 °C starting in the stage of exponential growth at 
an OD600 between 0.6 and 0.8.  
 
For His-tagged proteins; E.coli expressing the corresponding protein was centrifuged and the 
pellets were lysed in STE buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA) 
supplemented with protease inhibitors. Next the bacteria suspension was supplemented 
with lysozyme to a final concentration 100 µg/ml and treated in a dounce homogenizer by 
pushing and pulling for 10 times followed by incubation at 4 °C for 15 min. The bacteria 
suspension was sonicated for 1 min (35 % amplitude) and centrifuged at 16.000 rpm for 30 
min at 4 °C. The supernatants were transferred into fresh tubes and pellets were discarded. 
 
For GST-tagged proteins; E.coli expressing the corresponding proteins were centrifuged and 
resuspendet in STE buffer that was supplemented with lysozyme to a final concentration of 
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100 µg/ml. After processing the bacteria suspensions in a dounce homogenizer and an 
incubation at 4 °C for 15 min, sarcosyl was added to a final concentration of 1.5 % (w/v) 
followed by an 1 min sonication (35 % amplitude) step. Subsequently bacteria lysates were 
centrifuged at 16.000 rpm for 30 min at 4 °C. Finally pellets were discarded and the 
supernatants were transferred into 15 ml reaction tubes and mixed with triton X-100 to a 
final concentration of 2 % (w/v). 
 
His- and GST-tagged fusion proteins were isolated from E. coli lysates by the addition of Ni-
NTA (QIAGEN) or glutathione Sepharose 4B (GST) (Macherey-Nagel) beads to the 
supernatants and an incubation o/n at 4 °C on a shaker. Beads coupled with proteins were 
collected from the bacteria suspension by centrifugation (2.000 rpm, 1 min) and washed five 
times with PBS supplemented with protease inhibitors. His- or GST-tagged fusion proteins 
that were coupled to beads were stored in PBS supplemented with inhibitors at 4 °C for 
short time. 
 
To avoid unspecific signals in the pull down experiments, lysates of COS7 cells were pre-
cleared by incubation with empty Ni-NTA or GST-beads for 1 h at 4 °C. Beads were separated 
from the lysates by centrifugation (2.000 rpm, 1 min). Afterwards GST- or His- tagged fusion 
proteins bound to beads were incubated with lysates of COS7 cells expressing the 
corresponding GFP fusion proteins at 4 °C o/n on a shaker. Ni-NTA or GST-beads alone were 
used as negative controls. Finally, beads were collected by centrifugation (2.000 rpm, 1 min) 
and washed 5 times with PBS supplemented with protease inhibitors.  
 
4.3.3 Western blot and quantitative analysis 
 
Protein samples collected from His- or GST--pull-down experiments were re-suspended in 
SDS sample buffer (0.5 M Tris-HCl, pH 6.8, 10 % Glycerol, 2 % sodium dodecyl sulfate (SDS), 
2.5 ‰ Bromophenol Blue) and heated for 5 min at 95 °C. Subsequently they were separated 
on 15 % sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE) and stained either with 
coomassie brilliant blue R 250 or transferred onto nitrocellulose membranes for western 
blot analysis. Western blot membranes were blocked with 5 % (w/v) non-fat milk powder 
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diluted in TBST buffer (0.1 M Tris-HCl pH 7.0, 0.5 M NaCl, 2 % Tween20 (v/v), 1 % Nonidet-P 
40 (w/v)) prior to the appropriate antibody detections. Primary antibodies were detected by 
using the according peroxidase-conjugated secondary antibodies and visualized by enhanced 
chemiluminescence (ECL) reactions with ECL solution (0.1 M Tris-HCl, pH 8.5, 2.5 mM 
luminol,  0.4 mM p-coumaric acid  in DMSO,  luminol, p-coumaric acid and 6.1 µl 30% H2O2 
per 10 ml ECL solution that were added immediately before the reaction).  
 
ECL reactions on nitrocellulose membranes were documented on X-ray films (GE Healthcare) 
and developed in a developing machine (OptiMax). Antibodies used for western blot analysis 
are summarized in table 4.2. Secondary antibodies were horseradish-peroxidase (POD) 
conjugated.  
 
Primary antibodies Dilution Resource 
Mouse monoclonal  
anti-GFP (K3-184-2)  
1:20 Noegel AA, et al., 2004 
Rabbit polyclonal  
anti-lamin A/C (H-110) 
1:500 Santa Cruz 
Rat monoclonal 
 anti-YL ½ α/β-tubulin 
1:20 Scholey AB, et al., 1992 
Rabbit polyclonal  
anti-GAPDH (FL-335) 
1:500 Santa Cruz 
 
Second antibodies Dilution Resource 
Anti-mouse-IgG 1:10.000 Sigma 
Anti-rabbit-IgG 1:10.000 Sigma 
 
Table 4.2 Antibodies used in western blot.  
Antibodies used in this study for western blot analysis are shown in this table, including specification about 
working dilution and reference or company. 
 
AlphaEaseFC software (version 4.0.0) was used to quantify band intensities on scanned X-ray 
films and coomassie gels. The expression levels of GFP-tagged proteins were normalized to 
coomassie stained GST-fusion proteins. The ratio between GST-nesprin-2 WT and GFP-LA WT 
was used as a reference and corresponds to 100 %. Binding intensities between mutated 
GFP tagged lamin A proteins and WT GST-nesprin-2 were compared to the WT. Data are 
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expressed as mean ± standard deviation. Statistical comparisons were operated by using 
unpaired student's t-tests. A difference was considered significant at a value of P<0.01. 
 
4.4 Immunofluorescence and microscopy 
 
Cells transfected with the plasmids of interest were transferred onto coverslips in 24-well 
plates. Cells grown on coverslips over 1 or 2 days were fixed with 4 % paraformaldehyde 
(PFA) (All the solutions used in IF were diluted in PBS) for 15 min and permeabilized with 0.5 
% Triton X-100 for 5 min followed by extensive washing with PBS buffer. Alternatively, cells 
were fixed and permeabilized with ice cold methanol for 10 min at -20 °C. The appropriate 
antibodies were diluted in blocking solution PBG (0.5 % BSA, 0.045 % fish gelatin, pH 7.4) to 
the working concentration and applied to the fixed cells after blocking them with PBG at RT 
for 30 min. Unbound antibodies were removed by washing with PBS prior to the incubation 
with the according secondary antibodies, nuclei were stained with 4, 6-diamino-2-
phenylindone (DAPI) added to the secondary antibodies. Coverslips were embedded in 
gelvatol (0.1 M Tris-HCl, pH 8.5, 10 % gelvatol (w/v), 25 % glycerol (v/v),  2.7 % 1, 4-
diazobicyclo-[2.2.2] octanes (DABCO, w/v, Sigma)) and left to dry and polymerize o/n at R.T.. 
Samples were analyzed by confocal laser scanning microscopy (TCS-SP, Leica). LAS-AF lite 
application suite software (soft version: 2.6.0 build 7266) from Leica and Photoshop (Adobe, 
soft version: 8.0) were used for analysis and preparation of the figures. 
 
Antibodies used in immunofluorescence analysis (IF) are shown in table 4.3. As secondary 
antibodies, Alexa Fluor 488/568 conjugates were applied.  
 
Primary antibodies Dilution Resource 
Rabbit polyclonal  
anti-nesprin-2 (pAbK1) 
1:500 Padmakumar VC, et al., 2004 
Mouse monoclonal  
anti-emerin (4G5) 
1:50 Acris 
Rabbit polyclonal  
anti-lamin B1 (ab16048) 
1:400 Abcam 
Rabbit polyclonal  1:200 Santa Cruz 
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anti-ZNF239 (H-24) 
Rabbit polyclonal  
anti-SREBP-1 (C-20) 
1:200 Santa Cruz 
Mouse monoclonal  
anti-NPC (MAb414) 
1:500 COVANCE 
Rabbit polyclonal  
anti-lamin A/C (H-102) 
1:500 Santa Cruz 
Mouse monoclonal anti-V5  1:200 Invitrogen 
 
Second antibodies Dilution Resource 
Alexa 568 goat anti-rabbit IgG 1:1.000 Sigma 
Alexa 568 Goat anti-mouse IgG 1:1.000 Sigma 
 
Table 4.3 Antibodies applied in immunofluorescence analysis.  
Antibodies used in this study for immunofluorescence are shown in this table, including specification about 
working dilution and company. 
 
4.5 Heat stress experiments 
 
Primary human fibroblasts transfected with plasmids encoding GFP-LA WT, GFP-LA Q432X or 
GFP-LA V415I were transferred onto coverslips in 24-well plates. Cells were grown on 
coverslips for one or two days at 37 °C in a humidified atmosphere with 5 % CO2 o/n. For 
heat shock, cells were placed in an incubator set at 42 °C for 15 min and fixed immediately 
after treatment with ice cold methanol at −20 °C for 10 min followed by 
immunofluorescence analysis as described before. Fibroblasts that were not exposed to heat 
stress were used as controls. 
 
4.6 Protein lysates from mouse tissues 
 
Nesprin-2-Giant KO mice were generated by our lab (Lüke Y, et al., 2008). Tissues were 
washed in ice-cold PBS to remove the blood, shock frozen in liquid nitrogen and stored at -
80 °C. Next 400 μl lysis buffer were applied per 100 mg tissue. After grinding the tissues 
within liquid nitrogen tissues were stored on ice for 15 min followed by 1 min sonication (35 
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% amplitude). After 30 min centrifugation at 12.000 rpm, -4° C, the samples were 
supplemented with SDS-loading buffer and separated on SDS-PAGE followed by coomassie 
blue staining or western blot analysis. 
 
4.7 Sequence alignment and lamin A fragment structure prediction  
 
Lamin sequence from H. sapiens lamin A (P02545), Mus musculus lamin A (P48678), and H. 
sapiens lamin B (P20700) were retrieved from UniProt database and aligned using clustalW2 
online program (Larkin MA, et al., 2007). The aligned sequence was performed by using 
ESPript 2.2 for representation (Gouet P, et al., 1999). For lamin A structural model 
construction, the lamin A fragment aa 351-490 that encompassing part of its N-terminal 
coil2B and C-terminal globular domain is modeled by using the MULTICOM server (Wang Z, 
et al., 2010). 1UFGA(C-terminal immunoglobulin like domain of mouse lamin A) (Dhe-
Paganon S, et al., 2002), 1IFRA (globular tail of human lamin A), and 2LLA (chain A of 
Mannose-6-phosphate/insulin-like growth factor II receptor) (Williams C, et al., 2012) were 
used as templates for modeling. The WT and exchanged amino acids corresponding to lamin 
A mutations analyzed in this study were generated by using SwissPDB Viewer v4.1.0 (Guex N 
and Peitsch MC, 1997) and the molecular surface was generated using pyMOL v1.3. 
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Appendix 
 
Abbreviations 
 
        aa                               Amino acid 
       ABD                            Actin-binding domains 
       CH                              Calponin homology 
       CMT                           Charcot-Marie-Tooth syndrome 
       DAPI                           4, 6-diamino-2-phenylindone 
       DMD                          Duchenne muscular dystrophy 
       DMEM                       Dulbecco`s modified Eagle medium 
       DMSO                        Dimethylsulfoxide 
       DNA                           Desoxyribonucleic acid 
       DTT                            DL-Dithiothreitol 
       ECL                            Enhanced chemiluminescence 
       EDMD                       Emery-Dreifuss muscular dystrophy 
       EDTA                         Ethylenediaminetetraacetic acid 
       ER                             Endoplasmic reticulum 
       ERK1/2                     Extracellular signal-regulated kinases I/2 
       FPLD                         Familial partial lipodystrophy 
       GAPDH                    Glycerinaldehydephosphate dehydrogenase 
       GFP                          Green fluorescent protein 
       GST                          Glutathione S-transferase 
       h                               Hour (s) 
       HGPS                       Hutchinson-Gilford progeria syndrome 
       IgG                           Immunglobulin 
       INM                         Inner nuclear membrane 
       IPTG                        Isopropyl-β-Dthiogalactopyranoside 
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       KASH                      Klarsicht, ANC1 and SYNE1 homology 
       kb                            Kilobases 
       kDa                         kilodalton 
       KO                          Knockout 
       LA                           Lamin A 
       LAP                        Lamina-associated polypeptide 
       LINC                       Linker of nucleoskeleton to the cytoskeleton 
       min                        Minute (s) 
       NE                          Nuclear envelope 
       Nesprins               Nuclear envelope spectrin repeat proteins 
       NPC                       Nuclear pore complexes 
       NLS                        Nuclear localization signal 
       Nups                     Nucleoporins 
       NT                         N-terminal 
       OD                         Optical density 
       ONM                     Outer nuclear membrane 
       o/n                        Overnight 
       P                            Pellet 
       PBS                        Phosphate buffered saline 
       PDB                        Protein date bank 
       PFA                        Paraformaldehyde 
       PMSF                     Phenylmethanesulfonyl fluoride 
       PNS                        Perinuclear space 
       POD                       Horseradish-peroxidase 
       sec                         Second (s) 
       SDS-PAGE            Sodium dodecyl sulfate polyacrylamide gels 
       SPN                       Supernatant 
       SR                          Spectrin repeats 
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       SREBP1                 Sterol regulatory element-binding protein 1 
       SUN                       Sad1 and UNC84 homology 
       Taq                        Thermophilus aquaticus 
       TBS                        Tris buffered saline 
       WB                         Western blot 
       WT                         Wild type 
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Amino acid code 
 
A Ala Alanine M Met Methionine 
 
C Cys Cysteine N Asn Asparagine 
 
D Asp Aspartic acid P  Pro Proline 
 
E Glu Glutamic acid Q Gln Glutamine 
 
F Phe Phenylalanine R Arg Arginine 
 
G Gly Glycine S Ser Serine 
 
H His Histidine T Thr Threonine 
 
I Ile Isoleucine V Val  
 
Valine 
K Lys Lysine W Trp Tryptophane 
 
L Leu Leucine Y Tyr Tyrosine 
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